EGR1 | Human | (+)-pilocarpine | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Pilocarpine results in increased expression of EGR1 mRNA | CTD | PMID:7968354 |
EGR1 | Human | (+)-pilocarpine | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | Atropine inhibits the reaction [Pilocarpine results in increased expression of EGR1 mRNA] and Pirenzepine inhibits the reaction [Pilocarpine results in increased expression of EGR1 mRNA] | CTD | PMID:7968354 |
EGR1 | Human | (-)-alpha-phellandrene | increases expression | EXP | | 6480464 | alpha phellandrene results in increased expression of EGR1 mRNA | CTD | PMID:25075043 |
EGR1 | Human | (-)-anisomycin | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | SB 203580 inhibits the reaction [Anisomycin results in increased expression of EGR1 mRNA] | CTD | PMID:9671412 |
EGR1 | Human | (-)-anisomycin | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | Anisomycin results in increased expression of EGR1 mRNA | CTD | PMID:9671412 |
EGR1 | Human | (-)-citrinin | increases expression | EXP | | 6480464 | Citrinin results in increased expression of EGR1 mRNA and Citrinin results in increased expression of EGR1 protein | CTD | PMID:19361540 |
EGR1 | Human | (-)-citrinin | multiple interactions | EXP | | 6480464 | U 0126 inhibits the reaction [Citrinin results in increased expression of EGR1 protein] | CTD | PMID:19361540 |
EGR1 | Human | (-)-demecolcine | increases expression | EXP | | 6480464 | Demecolcine results in increased expression of EGR1 mRNA | CTD | PMID:23649840 |
EGR1 | Human | (-)-epigallocatechin 3-gallate | multiple interactions | EXP | | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of EGR1 mRNA and epigallocatechin gallate inhibits the reaction [potassium chromate(VI) results in increased expression of EGR1 mRNA] | CTD | PMID:22079256 |
EGR1 | Human | (-)-epigallocatechin 3-gallate | decreases expression | EXP | | 6480464 | epigallocatechin gallate results in decreased expression of EGR1 mRNA | CTD | PMID:32512070 |
EGR1 | Human | (-)-epigallocatechin 3-gallate | increases expression | EXP | | 6480464 | epigallocatechin gallate results in increased expression of EGR1 mRNA | CTD | PMID:22079256 |
EGR1 | Human | (1->4)-beta-D-glucan | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of EGR1 mRNA | CTD | PMID:36331819 |
EGR1 | Human | (20R)-protopanaxadiol | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | protopanaxadiol inhibits the reaction [Scopolamine results in decreased expression of EGR1 protein] | CTD | PMID:29133030 |
EGR1 | Human | (R)-noradrenaline | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Norepinephrine results in increased expression of EGR1 | CTD | PMID:7905536 |
EGR1 | Human | (S)-amphetamine | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | [Caffeine co-treated with Dextroamphetamine] affects the expression of EGR1 mRNA more ... | CTD | PMID:1347779 and PMID:16771831 |
EGR1 | Human | (S)-amphetamine | affects expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Dextroamphetamine affects the expression of EGR1 mRNA | CTD | PMID:17049170 |
EGR1 | Human | (S)-amphetamine | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Dextroamphetamine results in increased expression of EGR1 mRNA | CTD | PMID:11750902 and PMID:1347779 |
EGR1 | Human | (S)-naringenin | multiple interactions | EXP | | 6480464 | [naringenin co-treated with bisphenol A] results in increased expression of EGR1 mRNA and [naringenin metabolite co-treated with bisphenol A] results in increased expression of EGR1 mRNA | CTD | PMID:36235125 |
EGR1 | Human | (S)-nicotine | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | Nicotine results in increased expression of EGR1 mRNA and Nicotine results in increased expression of EGR1 protein | CTD | PMID:17456735 and PMID:31622651 |
EGR1 | Human | (S)-nicotine | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Nicotine results in increased expression of EGR1 mRNA and Nicotine results in increased expression of EGR1 protein | CTD | PMID:29486207 and PMID:31622651 |
EGR1 | Human | (S)-nicotine | multiple interactions | EXP | | 6480464 | [triethyl-(beta-4-stilbenoxyethyl)ammonium inhibits the reaction [Nicotine promotes the reaction [EGR1 protein binds to FGF2 promoter]]] which results in decreased expression of FGF2 mRNA more ... | CTD | PMID:22198237 and PMID:29486207 |
EGR1 | Human | (S)-nicotine | increases expression | EXP | | 6480464 | Nicotine results in increased expression of EGR1 mRNA and Nicotine results in increased expression of EGR1 protein | CTD | PMID:22198237 and PMID:29486207 |
EGR1 | Human | (S)-nicotine | decreases expression | ISO | Egr1 (Mus musculus) | 6480464 | Nicotine results in decreased expression of EGR1 mRNA | CTD | PMID:17997037 and PMID:21955143 |
EGR1 | Human | (S)-nicotine | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | [Nicotine co-treated with 1-Methyl-4-phenyl-1 more ... | CTD | PMID:20230807 |
EGR1 | Human | 1,10-phenanthroline | increases expression | EXP | | 6480464 | 1 and 10-phenanthroline results in increased expression of EGR1 mRNA | CTD | PMID:19502547 |
EGR1 | Human | 1,2-dichloroethane | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | ethylene dichloride results in increased expression of EGR1 mRNA | CTD | PMID:28189721 and PMID:28960355 |
EGR1 | Human | 1,2-dimethylhydrazine | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | [APC protein affects the susceptibility to 1 and 2-Dimethylhydrazine] which results in increased expression of EGR1 mRNA | CTD | PMID:27840820 |
EGR1 | Human | 1,2-dimethylhydrazine | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of EGR1 mRNA | CTD | PMID:22206623 |
EGR1 | Human | 1,4-dioxane | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | 1 and 4-dioxane results in increased expression of EGR1 mRNA | CTD | PMID:33693819 |
EGR1 | Human | 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | decreases expression | ISO | Egr1 (Mus musculus) | 6480464 | 1-Methyl-4-phenyl-1 more ... | CTD | PMID:20230807 and PMID:28801915 |
EGR1 | Human | 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | [Nicotine co-treated with 1-Methyl-4-phenyl-1 more ... | CTD | PMID:20230807 |
EGR1 | Human | 1-naphthyl isothiocyanate | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | [FGA gene mutant form results in increased susceptibility to 1-Naphthylisothiocyanate] which results in increased expression of EGR1 mRNA more ... | CTD | PMID:15913567 more ... |
EGR1 | Human | 1-naphthyl isothiocyanate | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | 1-Naphthylisothiocyanate results in increased expression of EGR1 mRNA | CTD | PMID:18364083 more ... |
EGR1 | Human | 1-naphthyl isothiocyanate | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | 1-Naphthylisothiocyanate results in increased expression of EGR1 mRNA and 1-Naphthylisothiocyanate results in increased expression of EGR1 protein | CTD | PMID:15913567 more ... |
EGR1 | Human | 1-naphthyl isothiocyanate | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | Dexamethasone promotes the reaction [1-Naphthylisothiocyanate results in increased expression of EGR1 mRNA] more ... | CTD | PMID:18590720 |
EGR1 | Human | 1-nitropyrene | increases expression | EXP | | 6480464 | 1-nitropyrene results in increased expression of EGR1 mRNA | CTD | PMID:21540303 |
EGR1 | Human | 13-HPODE | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | [13-hydroperoxy-9 more ... | CTD | PMID:22135674 |
EGR1 | Human | 15-deoxy-Delta(12,14)-prostaglandin J2 | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | 15-deoxy-delta(12 more ... | CTD | PMID:12468449 |
EGR1 | Human | 17alpha-ethynylestradiol | decreases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Ethinyl Estradiol results in decreased expression of EGR1 mRNA | CTD | PMID:12655037 |
EGR1 | Human | 17alpha-ethynylestradiol | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | Ethinyl Estradiol results in increased expression of EGR1 mRNA and Ethinyl Estradiol results in increased expression of EGR1 protein | CTD | PMID:36329302 |
EGR1 | Human | 17alpha-ethynylestradiol | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | [Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in decreased expression of EGR1 mRNA more ... | CTD | PMID:36329302 and PMID:37844793 |
EGR1 | Human | 17alpha-ethynylestradiol | affects expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Ethinyl Estradiol affects the expression of EGR1 mRNA | CTD | PMID:17351261 more ... |
EGR1 | Human | 17alpha-ethynylestradiol | affects expression | EXP | | 6480464 | Ethinyl Estradiol affects the expression of EGR1 mRNA | CTD | PMID:20170705 and PMID:26865667 |
EGR1 | Human | 17alpha-ethynylestradiol | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Ethinyl Estradiol results in increased expression of EGR1 mRNA | CTD | PMID:12075121 and PMID:16174780 |
EGR1 | Human | 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of EGR1 mRNA | CTD | PMID:18936297 |
EGR1 | Human | 17beta-estradiol | affects expression | ISO | Egr1 (Mus musculus) | 6480464 | Estradiol affects the expression of EGR1 mRNA | CTD | PMID:15598610 |
EGR1 | Human | 17beta-estradiol | affects expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Estradiol affects the expression of EGR1 mRNA | CTD | PMID:32145629 |
EGR1 | Human | 17beta-estradiol | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | fulvestrant inhibits the reaction [Estradiol results in increased expression of EGR1 mRNA] more ... | CTD | PMID:25461906 |
EGR1 | Human | 17beta-estradiol | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | Estradiol results in increased expression of EGR1 mRNA and Estradiol results in increased expression of EGR1 protein | CTD | PMID:14664709 more ... |
EGR1 | Human | 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of EGR1 mRNA | CTD | PMID:19153601 more ... |
EGR1 | Human | 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of EGR1 mRNA | CTD | PMID:17984146 and PMID:19167446 |
EGR1 | Human | 17beta-estradiol | affects expression | EXP | | 6480464 | Estradiol affects the expression of EGR1 mRNA | CTD | PMID:23461915 |
EGR1 | Human | 17beta-estradiol | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Estradiol results in increased expression of EGR1 mRNA and Estradiol results in increased expression of EGR1 mRNA alternative form | CTD | PMID:1717835 and PMID:8344219 |
EGR1 | Human | 17beta-estradiol | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | Dactinomycin inhibits the reaction [Estradiol results in increased expression of EGR1 mRNA] | CTD | PMID:1717835 |
EGR1 | Human | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with EGF protein] results in increased expression of EGR1 mRNA more ... | CTD | PMID:17404688 more ... |
EGR1 | Human | 17beta-hydroxy-5alpha-androstan-3-one | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | Dihydrotestosterone results in increased expression of EGR1 mRNA and Dihydrotestosterone results in increased expression of EGR1 protein | CTD | PMID:17023530 and PMID:30974244 |
EGR1 | Human | 17beta-hydroxy-5alpha-androstan-3-one | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | cypermethrin inhibits the reaction [Dihydrotestosterone results in increased expression of EGR1 mRNA] and cypermethrin inhibits the reaction [Dihydrotestosterone results in increased expression of EGR1 protein] | CTD | PMID:30974244 |
EGR1 | Human | 2,2',4,4',5,5'-hexachlorobiphenyl | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | 2 more ... | CTD | PMID:20959002 |
EGR1 | Human | 2,2',4,4',5,5'-hexachlorobiphenyl | increases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:38568856 |
EGR1 | Human | 2,2',4,4'-Tetrabromodiphenyl ether | increases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:19095052 and PMID:31173147 |
EGR1 | Human | 2,2',5,5'-tetrachlorobiphenyl | decreases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:36804509 |
EGR1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin promotes the reaction [EGR1 protein binds to PTGES promoter] and Tetrachlorodibenzodioxin promotes the reaction [EGR1 protein binds to PTGS2 promoter] | CTD | PMID:25015655 |
EGR1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of EGR1 mRNA | CTD | PMID:33387578 |
EGR1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Egr1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of EGR1 mRNA | CTD | PMID:21570461 and PMID:26377647 |
EGR1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of EGR1 mRNA | CTD | PMID:20959002 more ... |
EGR1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of EGR1 mRNA | CTD | PMID:16039398 more ... |
EGR1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of EGR1 mRNA | CTD | PMID:22298810 |
EGR1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of EGR1 mRNA | CTD | PMID:22298810 |
EGR1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of EGR1 mRNA and Tetrachlorodibenzodioxin results in increased expression of EGR1 protein | CTD | PMID:12377990 more ... |
EGR1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases degradation | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased degradation of EGR1 mRNA | CTD | PMID:15342960 |
EGR1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Egr1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of EGR1 mRNA | CTD | PMID:24058054 |
EGR1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of EGR1 mRNA | CTD | PMID:16962184 more ... |
EGR1 | Human | 2,4,6-trinitrotoluene | affects expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Trinitrotoluene affects the expression of EGR1 mRNA | CTD | PMID:21346803 |
EGR1 | Human | 2,4-dibromophenyl 2,4,5-tribromophenyl ether | affects expression | ISO | Egr1 (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:38648751 |
EGR1 | Human | 2,4-dinitrotoluene | affects expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | 2 and 4-dinitrotoluene affects the expression of EGR1 mRNA | CTD | PMID:21346803 |
EGR1 | Human | 2,6-dichloroindophenol | multiple interactions | EXP | | 6480464 | [2 and 6-Dichloroindophenol co-treated with NQO1 protein polymorphism] results in increased expression of EGR1 mRNA | CTD | PMID:21034357 |
EGR1 | Human | 2,6-dinitrotoluene | affects expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | 2 and 6-dinitrotoluene affects the expression of EGR1 mRNA | CTD | PMID:21346803 |
EGR1 | Human | 2-(4-iodo-2,5-dimethoxyphenyl)-1-methylethylamine | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | [Poly I-C results in increased susceptibility to 4-iodo-2 more ... | CTD | PMID:24889602 |
EGR1 | Human | 2-(4-iodo-2,5-dimethoxyphenyl)-1-methylethylamine | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | 4-iodo-2 and 5-dimethoxyphenylisopropylamine results in increased expression of EGR1 mRNA | CTD | PMID:24889602 |
EGR1 | Human | 2-acetamidofluorene | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | 2-Acetylaminofluorene results in increased expression of EGR1 mRNA | CTD | PMID:19167416 |
EGR1 | Human | 2-acetyl-1-alkyl-sn-glycero-3-phosphocholine | increases expression | EXP | | 6480464 | Platelet Activating Factor results in increased expression of EGR1 mRNA | CTD | PMID:16386258 |
EGR1 | Human | 2-butoxyethanol | decreases expression | ISO | Egr1 (Mus musculus) | 6480464 | n-butoxyethanol results in decreased expression of EGR1 mRNA | CTD | PMID:19812364 |
EGR1 | Human | 2-butoxyethanol | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | n-butoxyethanol results in increased expression of EGR1 mRNA | CTD | PMID:19812364 |
EGR1 | Human | 2-methylcholine | affects expression | EXP | | 6480464 | beta-methylcholine affects the expression of EGR1 mRNA | CTD | PMID:21179406 |
EGR1 | Human | 22-Hydroxycholesterol | increases expression | EXP | | 6480464 | 22-hydroxycholesterol results in increased expression of EGR1 mRNA | CTD | PMID:19426978 |
EGR1 | Human | 3',5'-cyclic AMP | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | [[Eugenol results in increased activity of OR5D18 protein] which results in increased abundance of Cyclic AMP] which results in increased expression of EGR1 mRNA | CTD | PMID:12767924 |
EGR1 | Human | 3,3',4,4',5-pentachlorobiphenyl | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | 3 more ... | CTD | PMID:20959002 and PMID:23196670 |
EGR1 | Human | 3,3',5,5'-tetrabromobisphenol A | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | tetrabromobisphenol A results in increased expression of EGR1 mRNA | CTD | PMID:25172293 |
EGR1 | Human | 3,4-dichloroaniline | decreases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | 3 and 4-dichloroaniline results in decreased expression of EGR1 mRNA | CTD | PMID:24172598 |
EGR1 | Human | 3,4-methylenedioxymethamphetamine | decreases expression | ISO | Egr1 (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of EGR1 mRNA | CTD | PMID:20188158 |
EGR1 | Human | 3-[3-(tert-butylsulfanyl)-1-(4-chlorobenzyl)-5-(propan-2-yl)-1H-indol-2-yl]-2,2-dimethylpropanoic acid | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | [13-hydroperoxy-9 more ... | CTD | PMID:22135674 |
EGR1 | Human | 3-\{1-[3-(dimethylamino)propyl]-1H-indol-3-yl\}-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | bisindolylmaleimide I inhibits the reaction [cypermethrin results in increased expression of EGR1 protein] | CTD | PMID:29149324 |
EGR1 | Human | 3-chloropropane-1,2-diol | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | alpha-Chlorohydrin results in increased expression of EGR1 mRNA | CTD | PMID:14644096 |
EGR1 | Human | 3-chloropropane-1,2-diol | decreases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | alpha-Chlorohydrin results in decreased expression of EGR1 mRNA | CTD | PMID:28522335 |
EGR1 | Human | 3-cyanoalanine | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | 3-cyanoalanine inhibits the reaction [[N more ... | CTD | PMID:29129814 |
EGR1 | Human | 3-phenylprop-2-enal | increases expression | EXP | | 6480464 | cinnamaldehyde results in increased expression of EGR1 mRNA | CTD | PMID:19000754 |
EGR1 | Human | 3H-1,2-dithiole-3-thione | decreases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | 1 and 2-dithiol-3-thione results in decreased expression of EGR1 mRNA | CTD | PMID:19162173 |
EGR1 | Human | 4,4'-diaminodiphenylmethane | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | 4 and 4'-diaminodiphenylmethane results in increased expression of EGR1 mRNA | CTD | PMID:18648102 |
EGR1 | Human | 4,4'-sulfonyldiphenol | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | bisphenol S results in increased expression of EGR1 mRNA | CTD | PMID:30951980 |
EGR1 | Human | 4,4'-sulfonyldiphenol | affects expression | ISO | Egr1 (Mus musculus) | 6480464 | bisphenol S affects the expression of EGR1 mRNA | CTD | PMID:31683443 |
EGR1 | Human | 4,4'-sulfonyldiphenol | decreases expression | ISO | Egr1 (Mus musculus) | 6480464 | bisphenol S results in decreased expression of EGR1 mRNA | CTD | PMID:33297965 and PMID:39298647 |
EGR1 | Human | 4,4'-sulfonyldiphenol | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | [bisphenol S co-treated with Tretinoin] results in decreased expression of EGR1 mRNA | CTD | PMID:30951980 |
EGR1 | Human | 4-aminobenzhydrazide | multiple interactions | EXP | | 6480464 | 4-aminobenzhydrazide inhibits the reaction [hydroxyhydroquinone results in increased expression of EGR1 mRNA] | CTD | PMID:24530881 |
EGR1 | Human | 4-hydroperoxycyclophosphamide | decreases expression | ISO | Egr1 (Mus musculus) | 6480464 | perfosfamide results in decreased expression of EGR1 mRNA | CTD | PMID:19429390 |
EGR1 | Human | 4-nitrotoluene | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | 4-nitrotoluene results in increased expression of EGR1 mRNA | CTD | PMID:15618236 |
EGR1 | Human | 5-aza-2'-deoxycytidine | increases expression | EXP | | 6480464 | Decitabine results in increased expression of EGR1 mRNA | CTD | PMID:21856257 |
EGR1 | Human | 5-aza-2'-deoxycytidine | affects expression | EXP | | 6480464 | Decitabine affects the expression of EGR1 mRNA | CTD | PMID:23300844 |
EGR1 | Human | 5-chloro-7-iodoquinolin-8-ol | increases expression | EXP | | 6480464 | Clioquinol results in increased expression of EGR1 mRNA | CTD | PMID:19502547 |
EGR1 | Human | 5-fluorouracil | multiple interactions | EXP | | 6480464 | EGR1 protein affects the reaction [Fluorouracil results in increased expression of THBS1 mRNA] more ... | CTD | PMID:18757417 |
EGR1 | Human | 5-fluorouracil | affects expression | EXP | | 6480464 | Fluorouracil affects the expression of EGR1 mRNA | CTD | PMID:15205334 and PMID:16557594 |
EGR1 | Human | 5-fluorouracil | affects localization | EXP | | 6480464 | Fluorouracil affects the localization of EGR1 protein | CTD | PMID:18757417 |
EGR1 | Human | 5-fluorouracil | increases expression | EXP | | 6480464 | Fluorouracil results in increased expression of EGR1 mRNA | CTD | PMID:18757417 |
EGR1 | Human | 5-fluorouracil | decreases expression | EXP | | 6480464 | Fluorouracil results in decreased expression of EGR1 mRNA | CTD | PMID:17039268 |
EGR1 | Human | 6-propyl-2-thiouracil | decreases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Propylthiouracil results in decreased expression of EGR1 mRNA | CTD | PMID:24780913 and PMID:25825206 |
EGR1 | Human | 7,12-dimethyltetraphene | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | 9 more ... | CTD | PMID:19480007 |
EGR1 | Human | 8-Br-cAMP | increases expression | EXP | | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of EGR1 mRNA | CTD | PMID:22079614 |
EGR1 | Human | acetaldehyde | increases expression | EXP | | 6480464 | Acetaldehyde results in increased expression of EGR1 mRNA | CTD | PMID:23416264 |
EGR1 | Human | acetylsalicylic acid | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Aspirin results in increased expression of EGR1 mRNA | CTD | PMID:12800193 |
EGR1 | Human | acrolein | increases expression | EXP | | 6480464 | Acrolein results in increased expression of EGR1 mRNA and Acrolein results in increased expression of EGR1 protein | CTD | PMID:20015449 |
EGR1 | Human | acrolein | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Acrolein results in increased expression of EGR1 mRNA | CTD | PMID:38090360 |
EGR1 | Human | acrolein | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | Acrolein results in increased expression of EGR1 mRNA | CTD | PMID:18515264 |
EGR1 | Human | acrylamide | decreases expression | ISO | Egr1 (Mus musculus) | 6480464 | Acrylamide results in decreased expression of EGR1 mRNA | CTD | PMID:29261810 and PMID:30807115 |
EGR1 | Human | acrylamide | increases expression | EXP | | 6480464 | Acrylamide results in increased expression of EGR1 mRNA | CTD | PMID:32763439 |
EGR1 | Human | acrylamide | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Acrylamide results in increased expression of EGR1 mRNA | CTD | PMID:36328537 |
EGR1 | Human | actinomycin D | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | Dactinomycin inhibits the reaction [Estradiol results in increased expression of EGR1 mRNA] | CTD | PMID:1717835 |
EGR1 | Human | afimoxifene | multiple interactions | EXP | | 6480464 | [BRAF protein co-treated with afimoxifene] results in increased expression of and results in increased activity of EGR1 protein and GPER1 protein affects the reaction [afimoxifene results in increased expression of EGR1 mRNA] | CTD | PMID:19153601 and PMID:25645941 |
EGR1 | Human | afimoxifene | increases expression | EXP | | 6480464 | afimoxifene results in increased expression of EGR1 mRNA | CTD | PMID:19153601 |
EGR1 | Human | aflatoxin B1 | affects expression | EXP | | 6480464 | Aflatoxin B1 affects the expression of EGR1 protein | CTD | PMID:20106945 |
EGR1 | Human | aflatoxin B1 | decreases methylation | EXP | | 6480464 | Aflatoxin B1 results in decreased methylation of EGR1 intron | CTD | PMID:30157460 |
EGR1 | Human | aflatoxin B1 | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Aflatoxin B1 results in increased expression of EGR1 mRNA | CTD | PMID:25378103 and PMID:33354967 |
EGR1 | Human | aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of EGR1 mRNA | CTD | PMID:21527772 more ... |
EGR1 | Human | aflatoxin B1 | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | Aflatoxin B1 results in increased expression of EGR1 mRNA | CTD | PMID:19770486 |
EGR1 | Human | Aflatoxin B2 alpha | decreases methylation | EXP | | 6480464 | aflatoxin B2 results in decreased methylation of EGR1 intron | CTD | PMID:30157460 |
EGR1 | Human | AH23848 | multiple interactions | EXP | | 6480464 | [6-isopropoxy-9-oxoxanthene-2-carboxylic acid co-treated with AH 23848] results in decreased expression of EGR1 protein | CTD | PMID:19407222 |
EGR1 | Human | aldehydo-D-glucose | multiple interactions | EXP | | 6480464 | Glucose promotes the reaction [AGT protein results in increased expression of EGR1 mRNA] and Valsartan inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased expression of EGR1 mRNA]] | CTD | PMID:19225232 |
EGR1 | Human | aldehydo-D-glucose | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of EGR1 mRNA | CTD | PMID:37567420 |
EGR1 | Human | aldehydo-D-glucose | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | Glucose results in increased expression of EGR1 mRNA | CTD | PMID:17178593 |
EGR1 | Human | aldehydo-D-glucose | increases expression | EXP | | 6480464 | Glucose results in increased expression of EGR1 mRNA | CTD | PMID:19225232 |
EGR1 | Human | all-trans-retinoic acid | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | [bisphenol F co-treated with Tretinoin] results in decreased expression of EGR1 mRNA more ... | CTD | PMID:15688020 more ... |
EGR1 | Human | all-trans-retinoic acid | decreases expression | ISO | Egr1 (Mus musculus) | 6480464 | Tretinoin results in decreased expression of EGR1 mRNA | CTD | PMID:36189433 |
EGR1 | Human | all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of EGR1 mRNA | CTD | PMID:16012519 more ... |
EGR1 | Human | all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | SUMO1 mutant form inhibits the reaction [Tretinoin results in increased expression of EGR1 mRNA] | CTD | PMID:24819975 |
EGR1 | Human | alpha-phellandrene | increases expression | EXP | | 6480464 | alpha phellandrene results in increased expression of EGR1 mRNA | CTD | PMID:25075043 |
EGR1 | Human | alpha-Zearalanol | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of EGR1 mRNA | CTD | PMID:35163327 |
EGR1 | Human | amiodarone | increases expression | EXP | | 6480464 | Amiodarone results in increased expression of EGR1 mRNA | CTD | PMID:19774075 and PMID:36586010 |
EGR1 | Human | ammonium chloride | affects expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Ammonium Chloride affects the expression of EGR1 mRNA | CTD | PMID:16483693 |
EGR1 | Human | amphetamine | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Amphetamine results in increased expression of EGR1 mRNA | CTD | PMID:10098858 more ... |
EGR1 | Human | amphetamine | decreases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Amphetamine results in decreased expression of EGR1 mRNA | CTD | PMID:15183010 |
EGR1 | Human | amphetamine | affects expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Amphetamine affects the expression of EGR1 mRNA | CTD | PMID:15496936 |
EGR1 | Human | amphetamine | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | Methylphenidate promotes the reaction [Amphetamine results in increased expression of EGR1 mRNA] | CTD | PMID:20020108 |
EGR1 | Human | amphibole asbestos | decreases expression | EXP | | 6480464 | Asbestos and Amphibole results in decreased expression of EGR1 protein | CTD | PMID:20855422 |
EGR1 | Human | anthra[1,9-cd]pyrazol-6(2H)-one | multiple interactions | EXP | | 6480464 | pyrazolanthrone inhibits the reaction [Curcumin results in increased expression of EGR1 protein] | CTD | PMID:18316600 |
EGR1 | Human | anthra[1,9-cd]pyrazol-6(2H)-one | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | pyrazolanthrone inhibits the reaction [arsenic trioxide results in increased expression of EGR1 mRNA] | CTD | PMID:15688020 |
EGR1 | Human | antimycin A | increases expression | EXP | | 6480464 | Antimycin A results in increased expression of EGR1 mRNA | CTD | PMID:33512557 |
EGR1 | Human | antirheumatic drug | decreases expression | EXP | | 6480464 | Antirheumatic Agents results in decreased expression of EGR1 mRNA | CTD | PMID:24449571 |
EGR1 | Human | arachidonic acid | increases expression | EXP | | 6480464 | Arachidonic Acid results in increased expression of EGR1 mRNA | CTD | PMID:16704987 |
EGR1 | Human | arachidonic acid | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | Arachidonic Acid results in increased expression of EGR1 mRNA | CTD | PMID:8764118 |
EGR1 | Human | aripiprazole | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Aripiprazole results in increased expression of EGR1 mRNA and Aripiprazole results in increased expression of EGR1 protein | CTD | PMID:17868501 |
EGR1 | Human | arsane | increases expression | EXP | | 6480464 | Arsenic results in increased expression of EGR1 mRNA | CTD | PMID:18039032 |
EGR1 | Human | arsane | decreases methylation | EXP | | 6480464 | Arsenic results in decreased methylation of EGR1 promoter | CTD | PMID:35490796 |
EGR1 | Human | arsane | affects expression | EXP | | 6480464 | Arsenic affects the expression of EGR1 mRNA | CTD | PMID:28793237 |
EGR1 | Human | arsane | multiple interactions | EXP | | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of EGR1 mRNA more ... | CTD | PMID:28793237 more ... |
EGR1 | Human | arsenic atom | increases expression | EXP | | 6480464 | Arsenic results in increased expression of EGR1 mRNA | CTD | PMID:18039032 |
EGR1 | Human | arsenic atom | decreases methylation | EXP | | 6480464 | Arsenic results in decreased methylation of EGR1 promoter | CTD | PMID:35490796 |
EGR1 | Human | arsenic atom | multiple interactions | EXP | | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of EGR1 mRNA more ... | CTD | PMID:28793237 more ... |
EGR1 | Human | arsenic atom | affects expression | EXP | | 6480464 | Arsenic affects the expression of EGR1 mRNA | CTD | PMID:28793237 |
EGR1 | Human | arsenite(3-) | multiple interactions | EXP | | 6480464 | arsenite promotes the reaction [G3BP1 protein binds to EGR1 mRNA] | CTD | PMID:32406909 |
EGR1 | Human | arsenite(3-) | increases expression | EXP | | 6480464 | arsenite results in increased expression of EGR1 mRNA and arsenite results in increased expression of EGR1 protein | CTD | PMID:23715767 and PMID:32406909 |
EGR1 | Human | arsenous acid | affects expression | EXP | | 6480464 | Arsenic Trioxide affects the expression of EGR1 mRNA | CTD | PMID:12749819 |
EGR1 | Human | arsenous acid | affects methylation | EXP | | 6480464 | Arsenic Trioxide affects the methylation of EGR1 promoter | CTD | PMID:26046465 |
EGR1 | Human | arsenous acid | decreases expression | EXP | | 6480464 | Arsenic Trioxide results in decreased expression of EGR1 mRNA | CTD | PMID:20458559 more ... |
EGR1 | Human | arsenous acid | decreases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Arsenic Trioxide results in decreased expression of EGR1 mRNA | CTD | PMID:29223816 |
EGR1 | Human | arsenous acid | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | Arsenic Trioxide results in increased expression of EGR1 mRNA | CTD | PMID:15073043 and PMID:15688020 |
EGR1 | Human | arsenous acid | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | pyrazolanthrone inhibits the reaction [Arsenic Trioxide results in increased expression of EGR1 mRNA] and Tretinoin promotes the reaction [Arsenic Trioxide results in increased expression of EGR1 mRNA] | CTD | PMID:15688020 |
EGR1 | Human | arsenous acid | increases expression | EXP | | 6480464 | Arsenic Trioxide results in increased expression of EGR1 mRNA | CTD | PMID:25258189 |
EGR1 | Human | arsenous acid | multiple interactions | EXP | | 6480464 | [Zidovudine co-treated with Arsenic Trioxide] results in increased expression of EGR1 mRNA | CTD | PMID:29910624 |
EGR1 | Human | ATP | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | Iodoacetates inhibits the reaction [Adenosine Triphosphate results in increased expression of EGR1 mRNA] more ... | CTD | PMID:10723097 |
EGR1 | Human | ATP | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Adenosine Triphosphate results in increased expression of EGR1 mRNA | CTD | PMID:10723097 |
EGR1 | Human | atrazine | decreases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Atrazine results in decreased expression of EGR1 mRNA and Atrazine results in decreased expression of EGR1 protein | CTD | PMID:30065202 and PMID:30580161 |
EGR1 | Human | atrazine | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Atrazine results in increased expression of EGR1 mRNA | CTD | PMID:36841081 |
EGR1 | Human | atropine | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | Atropine inhibits the reaction [Pilocarpine results in increased expression of EGR1 mRNA] | CTD | PMID:7968354 |
EGR1 | Human | Aurin | increases expression | EXP | | 6480464 | aurin results in increased expression of EGR1 mRNA | CTD | PMID:25477506 |
EGR1 | Human | Azaspiracid | increases expression | EXP | | 6480464 | azaspiracid results in increased expression of EGR1 mRNA | CTD | PMID:28939011 |
EGR1 | Human | azathioprine | increases expression | EXP | | 6480464 | Azathioprine results in increased expression of EGR1 mRNA | CTD | PMID:22623647 |
EGR1 | Human | bazedoxifene | increases expression | EXP | | 6480464 | bazedoxifene results in increased expression of EGR1 mRNA | CTD | PMID:19914376 |
EGR1 | Human | benzalkonium chloride | increases expression | EXP | | 6480464 | Benzalkonium Compounds results in increased expression of EGR1 mRNA | CTD | PMID:25377654 |
EGR1 | Human | benzene | decreases expression | ISO | Egr1 (Mus musculus) | 6480464 | Benzene results in decreased expression of EGR1 mRNA | CTD | PMID:15120971 and PMID:15122651 |
EGR1 | Human | benzene | increases expression | EXP | | 6480464 | Benzene results in increased expression of EGR1 mRNA | CTD | PMID:21843810 |
EGR1 | Human | benzene | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | [Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in decreased expression of EGR1 mRNA | CTD | PMID:17905399 |
EGR1 | Human | benzene-1,2,4-triol | increases expression | EXP | | 6480464 | hydroxyhydroquinone results in increased expression of EGR1 mRNA | CTD | PMID:24530881 and PMID:39245080 |
EGR1 | Human | benzene-1,2,4-triol | multiple interactions | EXP | | 6480464 | 4-aminobenzhydrazide inhibits the reaction [hydroxyhydroquinone results in increased expression of EGR1 mRNA] | CTD | PMID:24530881 |
EGR1 | Human | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of EGR1 mRNA | CTD | PMID:15808406 |
EGR1 | Human | benzo[a]pyrene | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of EGR1 mRNA | CTD | PMID:21569818 and PMID:21964900 |
EGR1 | Human | benzo[a]pyrene | decreases expression | ISO | Egr1 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of EGR1 mRNA | CTD | PMID:19770486 |
EGR1 | Human | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of EGR1 mRNA and Benzo(a)pyrene results in increased expression of EGR1 protein | CTD | PMID:15342960 more ... |
EGR1 | Human | benzo[a]pyrene | affects activity | EXP | | 6480464 | Benzo(a)pyrene affects the activity of EGR1 protein | CTD | PMID:20624995 |
EGR1 | Human | benzo[a]pyrene diol epoxide I | decreases expression | EXP | | 6480464 | 7 more ... | CTD | PMID:20018196 |
EGR1 | Human | benzo[a]pyrene diol epoxide I | increases expression | EXP | | 6480464 | 7 more ... | CTD | PMID:19150397 and PMID:26238291 |
EGR1 | Human | benzo[b]fluoranthene | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | benzo(b)fluoranthene results in increased expression of EGR1 mRNA | CTD | PMID:26377693 |
EGR1 | Human | benzo[b]fluoranthene | increases expression | EXP | | 6480464 | benzo(b)fluoranthene results in increased expression of EGR1 mRNA and benzo(b)fluoranthene results in increased expression of EGR1 protein | CTD | PMID:29787794 |
EGR1 | Human | Benzoyl peroxide | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | Benzoyl Peroxide results in increased expression of EGR1 mRNA | CTD | PMID:15920718 |
EGR1 | Human | beta-lapachone | increases expression | EXP | | 6480464 | beta-lapachone results in increased expression of EGR1 mRNA | CTD | PMID:38218311 |
EGR1 | Human | beta-naphthoflavone | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of EGR1 mRNA | CTD | PMID:18164116 |
EGR1 | Human | betamethasone | affects expression | EXP | | 6480464 | Betamethasone affects the expression of EGR1 mRNA | CTD | PMID:23461915 |
EGR1 | Human | bexarotene | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | [bexarotene co-treated with Tamoxifen] results in decreased expression of EGR1 mRNA | CTD | PMID:17630414 |
EGR1 | Human | bis(2-chloroethyl) sulfide | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | Mustard Gas results in increased expression of EGR1 mRNA | CTD | PMID:18955075 |
EGR1 | Human | bis(2-ethylhexyl) phthalate | decreases expression | ISO | Egr1 (Mus musculus) | 6480464 | Diethylhexyl Phthalate results in decreased expression of EGR1 mRNA | CTD | PMID:19850644 |
EGR1 | Human | bis(2-ethylhexyl) phthalate | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | Diethylhexyl Phthalate results in increased expression of EGR1 mRNA | CTD | PMID:33754040 |
EGR1 | Human | bis(2-ethylhexyl) phthalate | decreases expression | EXP | | 6480464 | Diethylhexyl Phthalate results in decreased expression of EGR1 mRNA | CTD | PMID:31163220 |
EGR1 | Human | bis(2-ethylhexyl) phthalate | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Diethylhexyl Phthalate results in increased expression of EGR1 mRNA | CTD | PMID:15728792 |
EGR1 | Human | bis(2-ethylhexyl) phthalate | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of EGR1 mRNA and PPARA protein promotes the reaction [Diethylhexyl Phthalate results in decreased expression of EGR1 mRNA] | CTD | PMID:19850644 and PMID:39150890 |
EGR1 | Human | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of EGR1 mRNA | CTD | PMID:20170705 and PMID:30903817 |
EGR1 | Human | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of EGR1 gene | CTD | PMID:31601247 |
EGR1 | Human | bisphenol A | decreases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of EGR1 mRNA | CTD | PMID:34947998 |
EGR1 | Human | bisphenol A | affects expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | bisphenol A affects the expression of EGR1 mRNA | CTD | PMID:30903817 and PMID:32145629 |
EGR1 | Human | bisphenol A | affects methylation | ISO | Egr1 (Mus musculus) | 6480464 | bisphenol A affects the methylation of EGR1 promoter | CTD | PMID:27334623 |
EGR1 | Human | bisphenol A | decreases expression | ISO | Egr1 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of EGR1 mRNA | CTD | PMID:25594700 and PMID:29161229 |
EGR1 | Human | bisphenol A | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of EGR1 mRNA | CTD | PMID:12075121 and PMID:25181051 |
EGR1 | Human | bisphenol A | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | bisphenol A results in increased expression of EGR1 mRNA and bisphenol A results in increased expression of EGR1 protein | CTD | PMID:25461906 and PMID:30951980 |
EGR1 | Human | bisphenol A | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | fulvestrant inhibits the reaction [bisphenol A results in increased expression of EGR1 mRNA] more ... | CTD | PMID:25461906 |
EGR1 | Human | bisphenol A | multiple interactions | EXP | | 6480464 | [naringenin co-treated with bisphenol A] results in increased expression of EGR1 mRNA more ... | CTD | PMID:22552965 and PMID:36235125 |
EGR1 | Human | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of EGR1 mRNA and bisphenol A results in increased expression of EGR1 protein | CTD | PMID:22552965 more ... |
EGR1 | Human | bisphenol AF | increases expression | EXP | | 6480464 | bisphenol AF results in increased expression of EGR1 mRNA | CTD | PMID:25912373 and PMID:29093337 |
EGR1 | Human | bisphenol AF | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | bisphenol AF results in increased expression of EGR1 mRNA | CTD | PMID:27567155 |
EGR1 | Human | bisphenol F | increases expression | EXP | | 6480464 | bisphenol F results in increased expression of EGR1 mRNA | CTD | PMID:33476716 |
EGR1 | Human | bisphenol F | decreases expression | EXP | | 6480464 | bisphenol F results in decreased expression of EGR1 mRNA | CTD | PMID:34774955 |
EGR1 | Human | bisphenol F | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | [bisphenol F co-treated with Tretinoin] results in decreased expression of EGR1 mRNA | CTD | PMID:30951980 |
EGR1 | Human | bisphenol F | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | bisphenol F results in increased expression of EGR1 mRNA | CTD | PMID:30951980 |
EGR1 | Human | bleomycin A2 | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | Bleomycin results in increased expression of EGR1 mRNA | CTD | PMID:19147827 |
EGR1 | Human | bleomycin A2 | affects expression | ISO | Egr1 (Mus musculus) | 6480464 | Bleomycin affects the expression of EGR1 mRNA | CTD | PMID:26345256 |
EGR1 | Human | bleomycin A2 | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | rosiglitazone inhibits the reaction [Bleomycin results in increased expression of EGR1 mRNA] | CTD | PMID:19147827 |
EGR1 | Human | bortezomib | increases expression | EXP | | 6480464 | Bortezomib results in increased expression of EGR1 mRNA | CTD | PMID:20471514 |
EGR1 | Human | bromoacetate | decreases expression | EXP | | 6480464 | bromoacetate results in decreased expression of EGR1 mRNA | CTD | PMID:19753638 |
EGR1 | Human | bromoacetate | increases expression | EXP | | 6480464 | bromoacetate results in increased expression of EGR1 mRNA | CTD | PMID:19753638 |
EGR1 | Human | buta-1,3-diene | decreases expression | ISO | Egr1 (Mus musculus) | 6480464 | 1 and 3-butadiene results in decreased expression of EGR1 mRNA | CTD | PMID:29038090 |
EGR1 | Human | butan-1-ol | multiple interactions | EXP | | 6480464 | [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of EGR1 mRNA | CTD | PMID:29432896 |
EGR1 | Human | butanal | increases expression | EXP | | 6480464 | butyraldehyde results in increased expression of EGR1 mRNA | CTD | PMID:26079696 |
EGR1 | Human | Butylbenzyl phthalate | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of EGR1 mRNA | CTD | PMID:39150890 |
EGR1 | Human | Butylbenzyl phthalate | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | butylbenzyl phthalate results in increased expression of EGR1 mRNA | CTD | PMID:32308655 |
EGR1 | Human | butyric acid | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Butyric Acid results in increased expression of EGR1 mRNA | CTD | PMID:12800193 |
EGR1 | Human | cadmium atom | affects expression | EXP | | 6480464 | Cadmium affects the expression of EGR1 mRNA | CTD | PMID:21694771 |
EGR1 | Human | cadmium atom | multiple interactions | EXP | | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of EGR1 mRNA and [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of EGR1 mRNA | CTD | PMID:35301059 and PMID:36602393 |
EGR1 | Human | cadmium atom | decreases expression | EXP | | 6480464 | Cadmium results in decreased expression of EGR1 mRNA | CTD | PMID:16439709 and PMID:24376830 |
EGR1 | Human | cadmium dichloride | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Cadmium Chloride results in increased expression of EGR1 mRNA | CTD | PMID:19010381 |
EGR1 | Human | cadmium dichloride | multiple interactions | EXP | | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of EGR1 mRNA and [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of EGR1 mRNA | CTD | PMID:35301059 and PMID:36602393 |
EGR1 | Human | cadmium dichloride | increases expression | EXP | | 6480464 | Cadmium Chloride results in increased expression of EGR1 mRNA | CTD | PMID:38382870 and PMID:38568856 |
EGR1 | Human | cadmium dichloride | decreases expression | EXP | | 6480464 | Cadmium Chloride results in decreased expression of EGR1 mRNA | CTD | PMID:26314618 |
EGR1 | Human | cadmium dichloride | decreases expression | ISO | Egr1 (Mus musculus) | 6480464 | Cadmium Chloride results in decreased expression of EGR1 mRNA | CTD | PMID:24982889 |
EGR1 | Human | cadmium dichloride | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | Cadmium Chloride results in increased expression of EGR1 mRNA | CTD | PMID:15501611 |
EGR1 | Human | cadmium dichloride | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of EGR1 mRNA] and Buthionine Sulfoximine promotes the reaction [Cadmium Chloride results in increased expression of EGR1 mRNA] | CTD | PMID:19010381 |
EGR1 | Human | cadmium dichloride | increases methylation | ISO | Egr1 (Rattus norvegicus) | 6480464 | Cadmium Chloride results in increased methylation of EGR1 promoter | CTD | PMID:22457795 |
EGR1 | Human | cadmium dichloride | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of EGR1 mRNA | CTD | PMID:19840844 |
EGR1 | Human | caffeine | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | Caffeine results in increased expression of EGR1 mRNA | CTD | PMID:10971643 |
EGR1 | Human | caffeine | decreases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Caffeine results in decreased expression of EGR1 mRNA | CTD | PMID:16771831 |
EGR1 | Human | caffeine | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | [Cocaine co-treated with Caffeine] results in increased expression of EGR1 mRNA and Cocaine promotes the reaction [Caffeine results in increased expression of EGR1 mRNA] | CTD | PMID:10971643 |
EGR1 | Human | caffeine | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | [Caffeine co-treated with Dextroamphetamine] affects the expression of EGR1 mRNA | CTD | PMID:16771831 |
EGR1 | Human | Calcimycin | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | Calcimycin results in increased expression of EGR1 mRNA | CTD | PMID:8764118 |
EGR1 | Human | calcitriol | increases expression | EXP | | 6480464 | Calcitriol results in increased expression of EGR1 mRNA | CTD | PMID:21592394 |
EGR1 | Human | calcitriol | multiple interactions | EXP | | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of EGR1 mRNA | CTD | PMID:21592394 |
EGR1 | Human | calcium atom | multiple interactions | EXP | | 6480464 | [[CXCL9 protein binds to and results in increased activity of CXCR3 protein] which results in increased abundance of Calcium] which results in increased expression of EGR1 mRNA and [Ionomycin results in increased abundance of Calcium] which results in increased expression of EGR1 protein | CTD | PMID:12517959 |
EGR1 | Human | calcium(0) | multiple interactions | EXP | | 6480464 | [[CXCL9 protein binds to and results in increased activity of CXCR3 protein] which results in increased abundance of Calcium] which results in increased expression of EGR1 mRNA and [Ionomycin results in increased abundance of Calcium] which results in increased expression of EGR1 protein | CTD | PMID:12517959 |
EGR1 | Human | camostat | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | mirdametinib inhibits the reaction [camostat results in increased expression of EGR1 mRNA] | CTD | PMID:25104499 |
EGR1 | Human | camostat | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | camostat results in increased expression of EGR1 mRNA | CTD | PMID:25104499 |
EGR1 | Human | cannabidiol | multiple interactions | EXP | | 6480464 | [Dronabinol co-treated with Cannabidiol] results in increased expression of EGR1 mRNA | CTD | PMID:26504004 |
EGR1 | Human | cannabidiol | decreases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Cannabidiol results in decreased expression of EGR1 protein | CTD | PMID:28344069 |
EGR1 | Human | cannabidiol | increases expression | EXP | | 6480464 | Cannabidiol results in increased expression of EGR1 mRNA | CTD | PMID:26504004 |
EGR1 | Human | capsaicin | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Capsaicin results in increased expression of EGR1 mRNA | CTD | PMID:20349343 |
EGR1 | Human | carbachol | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | Tetradecanoylphorbol Acetate inhibits the reaction [Carbachol results in increased expression of EGR1 mRNA] | CTD | PMID:2005087 |
EGR1 | Human | carbachol | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Carbachol results in increased expression of EGR1 mRNA | CTD | PMID:2005087 |
EGR1 | Human | carbon monoxide | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | Carbon Monoxide inhibits the reaction [Lipopolysaccharides results in increased expression of EGR1 mRNA] more ... | CTD | PMID:22046279 |
EGR1 | Human | carbon nanotube | decreases expression | EXP | | 6480464 | Nanotubes and Carbon results in decreased expression of EGR1 mRNA | CTD | PMID:15585362 |
EGR1 | Human | carbon nanotube | decreases expression | ISO | Egr1 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25620056 |
EGR1 | Human | carbonyl cyanide p-trifluoromethoxyphenylhydrazone | decreases expression | EXP | | 6480464 | Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone results in decreased expression of EGR1 mRNA | CTD | PMID:16039398 |
EGR1 | Human | carbonyl sulfide | decreases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | carbonyl sulfide results in decreased expression of EGR1 mRNA | CTD | PMID:19395590 |
EGR1 | Human | carrageenan | increases expression | EXP | | 6480464 | Carrageenan results in increased expression of EGR1 protein | CTD | PMID:22561171 |
EGR1 | Human | carrageenan | multiple interactions | EXP | | 6480464 | 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [Carrageenan results in increased expression of EGR1 protein] more ... | CTD | PMID:22561171 |
EGR1 | Human | cefaloridine | decreases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Cephaloridine results in decreased expression of EGR1 mRNA | CTD | PMID:18500788 |
EGR1 | Human | chenodeoxycholic acid | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | EGR1 promotes the reaction [Chenodeoxycholic Acid results in increased expression of CCL2 mRNA] more ... | CTD | PMID:19931294 and PMID:21224055 |
EGR1 | Human | chenodeoxycholic acid | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | Chenodeoxycholic Acid results in increased expression of EGR1 mRNA and Chenodeoxycholic Acid results in increased expression of EGR1 protein | CTD | PMID:19931294 and PMID:21224055 |
EGR1 | Human | chlornitrofen | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | 2 more ... | CTD | PMID:15110079 |
EGR1 | Human | chloropicrin | increases expression | EXP | | 6480464 | chloropicrin results in increased expression of EGR1 mRNA | CTD | PMID:26352163 and PMID:28476498 |
EGR1 | Human | chloroprene | decreases expression | ISO | Egr1 (Mus musculus) | 6480464 | Chloroprene results in decreased expression of EGR1 mRNA | CTD | PMID:23125180 |
EGR1 | Human | chlorpromazine | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Chlorpromazine results in increased expression of EGR1 | CTD | PMID:20368687 |
EGR1 | Human | chlorpromazine | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | [EGR1 binds to CDKN1A promoter] promotes the reaction [Chlorpromazine results in increased expression of CDKN1A mRNA] more ... | CTD | PMID:20368687 |
EGR1 | Human | chlorpyrifos | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of EGR1 mRNA | CTD | PMID:32715474 more ... |
EGR1 | Human | chlorpyrifos | decreases expression | ISO | Egr1 (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of EGR1 mRNA | CTD | PMID:27905518 |
EGR1 | Human | chlorpyrifos | decreases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Chlorpyrifos results in decreased expression of EGR1 mRNA | CTD | PMID:27905518 |
EGR1 | Human | chlorpyrifos | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | [Chlorpyrifos co-treated with Ethylenethiourea] results in decreased expression of EGR1 mRNA | CTD | PMID:27905518 |
EGR1 | Human | choline | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Choline results in increased expression of EGR1 mRNA and Choline results in increased expression of EGR1 protein | CTD | PMID:17264169 |
EGR1 | Human | choline | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of EGR1 mRNA and [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of EGR1 gene | CTD | PMID:20938992 and PMID:33549593 |
EGR1 | Human | chromium(6+) | affects expression | ISO | Egr1 (Mus musculus) | 6480464 | chromium hexavalent ion affects the expression of EGR1 mRNA | CTD | PMID:28472532 |
EGR1 | Human | chromium(6+) | multiple interactions | EXP | | 6480464 | [zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of EGR1 mRNA | CTD | PMID:38479592 |
EGR1 | Human | chromium(6+) | affects expression | EXP | | 6480464 | chromium hexavalent ion affects the expression of EGR1 mRNA | CTD | PMID:30690063 |
EGR1 | Human | ciguatoxin CTX1B | affects expression | ISO | Egr1 (Mus musculus) | 6480464 | Ciguatoxins affects the expression of EGR1 mRNA | CTD | PMID:18353800 |
EGR1 | Human | cis-caffeic acid | multiple interactions | EXP | | 6480464 | caffeic acid affects the reaction [Acetaminophen results in increased expression of and affects the localization of EGR1 protein] and caffeic acid inhibits the reaction [Acetaminophen results in increased expression of EGR1 mRNA] | CTD | PMID:27720869 |
EGR1 | Human | cisplatin | multiple interactions | EXP | | 6480464 | [Cisplatin co-treated with jinfukang] results in decreased expression of EGR1 mRNA and EGR1 protein promotes the reaction [Cisplatin results in increased activity of CASP9 protein] | CTD | PMID:21271225 and PMID:27392435 |
EGR1 | Human | cisplatin | decreases expression | EXP | | 6480464 | Cisplatin results in decreased expression of EGR1 mRNA | CTD | PMID:27392435 |
EGR1 | Human | cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of EGR1 mRNA | CTD | PMID:33545341 |
EGR1 | Human | cisplatin | affects expression | EXP | | 6480464 | Cisplatin affects the expression of EGR1 mRNA | CTD | PMID:23300844 |
EGR1 | Human | cisplatin | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | Cisplatin results in increased expression of EGR1 mRNA | CTD | PMID:21151649 |
EGR1 | Human | cisplatin | increases response to substance | EXP | | 6480464 | EGR1 protein results in increased susceptibility to Cisplatin | CTD | PMID:21271225 |
EGR1 | Human | clofibrate | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of EGR1 mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of EGR1 mRNA] | CTD | PMID:17585979 |
EGR1 | Human | clofibrate | decreases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Clofibrate results in decreased expression of EGR1 mRNA | CTD | PMID:15033592 |
EGR1 | Human | clofibrate | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | Clofibrate analog results in increased expression of EGR1 mRNA | CTD | PMID:8764118 |
EGR1 | Human | clofibrate | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Clofibrate results in increased expression of EGR1 mRNA | CTD | PMID:15585944 |
EGR1 | Human | clozapine | decreases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Clozapine results in decreased expression of EGR1 mRNA and Clozapine results in decreased expression of EGR1 protein | CTD | PMID:17028028 and PMID:18208916 |
EGR1 | Human | cobalt atom | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | [Tungsten co-treated with Nickel co-treated with Cobalt] results in increased expression of EGR1 mRNA | CTD | PMID:24619124 |
EGR1 | Human | cobalt dichloride | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | cobaltous chloride results in increased expression of EGR1 mRNA | CTD | PMID:24619124 |
EGR1 | Human | cocaine | affects expression | ISO | Egr1 (Mus musculus) | 6480464 | Cocaine affects the expression of EGR1 mRNA | CTD | PMID:18355967 |
EGR1 | Human | cocaine | decreases expression | ISO | Egr1 (Mus musculus) | 6480464 | Cocaine deficiency results in decreased expression of EGR1 mRNA | CTD | PMID:27126842 |
EGR1 | Human | cocaine | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | Cocaine results in increased expression of EGR1 protein | CTD | PMID:16339038 |
EGR1 | Human | cocaine | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | NPPC protein inhibits the reaction [Cocaine results in increased expression of EGR1 mRNA] | CTD | PMID:11860464 |
EGR1 | Human | cocaine | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Cocaine results in increased expression of EGR1 mRNA and Cocaine results in increased expression of EGR1 protein | CTD | PMID:11860464 more ... |
EGR1 | Human | cocaine | increases response to substance | ISO | Egr1 (Rattus norvegicus) | 6480464 | EGR1 results in increased susceptibility to Cocaine | CTD | PMID:16738229 |
EGR1 | Human | cocaine | affects expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Cocaine affects the expression of EGR1 mRNA | CTD | PMID:17851536 more ... |
EGR1 | Human | cocaine | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | [Cocaine co-treated with Caffeine] results in increased expression of EGR1 mRNA and Cocaine promotes the reaction [Caffeine results in increased expression of EGR1 mRNA] | CTD | PMID:10971643 |
EGR1 | Human | colforsin daropate hydrochloride | decreases expression | EXP | | 6480464 | Colforsin results in decreased expression of EGR1 mRNA and Colforsin results in decreased expression of EGR1 protein | CTD | PMID:29802914 |
EGR1 | Human | colforsin daropate hydrochloride | multiple interactions | EXP | | 6480464 | Colforsin inhibits the reaction [Ethanol results in increased expression of EGR1 mRNA] more ... | CTD | PMID:29802914 |
EGR1 | Human | copper atom | multiple interactions | EXP | | 6480464 | [Disulfiram binds to Copper] which results in decreased expression of EGR1 mRNA and [NSC 689534 binds to Copper] which results in increased expression of EGR1 mRNA | CTD | PMID:20971185 and PMID:24690739 |
EGR1 | Human | copper atom | increases expression | EXP | | 6480464 | Copper results in increased expression of EGR1 | CTD | PMID:24403277 |
EGR1 | Human | copper atom | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of EGR1 mRNA | CTD | PMID:15467011 |
EGR1 | Human | copper atom | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Copper deficiency results in increased expression of EGR1 mRNA | CTD | PMID:17418555 |
EGR1 | Human | copper(0) | multiple interactions | EXP | | 6480464 | [Disulfiram binds to Copper] which results in decreased expression of EGR1 mRNA and [NSC 689534 binds to Copper] which results in increased expression of EGR1 mRNA | CTD | PMID:20971185 and PMID:24690739 |
EGR1 | Human | copper(0) | increases expression | EXP | | 6480464 | Copper results in increased expression of EGR1 | CTD | PMID:24403277 |
EGR1 | Human | copper(0) | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of EGR1 mRNA | CTD | PMID:15467011 |
EGR1 | Human | copper(0) | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Copper deficiency results in increased expression of EGR1 mRNA | CTD | PMID:17418555 |
EGR1 | Human | copper(II) chloride | affects expression | EXP | | 6480464 | cupric chloride affects the expression of EGR1 mRNA | CTD | PMID:17211630 |
EGR1 | Human | copper(II) chloride | increases expression | EXP | | 6480464 | cupric chloride results in increased expression of EGR1 mRNA | CTD | PMID:38568856 |
EGR1 | Human | copper(II) sulfate | increases expression | EXP | | 6480464 | Copper Sulfate results in increased expression of EGR1 mRNA | CTD | PMID:19549813 |
EGR1 | Human | coumestrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EGR1 mRNA | CTD | PMID:19167446 |
EGR1 | Human | crocidolite asbestos | affects expression | EXP | | 6480464 | Asbestos and Crocidolite affects the expression of EGR1 mRNA | CTD | PMID:25757056 |
EGR1 | Human | crocidolite asbestos | multiple interactions | EXP | | 6480464 | clinoptilolite inhibits the reaction [Asbestos and Crocidolite results in increased expression of EGR1 mRNA] | CTD | PMID:32123850 |
EGR1 | Human | crocidolite asbestos | increases expression | EXP | | 6480464 | Asbestos and Crocidolite results in increased expression of EGR1 mRNA | CTD | PMID:18687144 more ... |
EGR1 | Human | CU-O LINKAGE | increases expression | EXP | | 6480464 | cupric oxide results in increased expression of EGR1 mRNA | CTD | PMID:22077320 |
EGR1 | Human | curcumin | multiple interactions | EXP | | 6480464 | EGR1 protein affects the reaction [Curcumin results in increased expression of CDKN1A protein] more ... | CTD | PMID:18316600 |
EGR1 | Human | curcumin | increases expression | EXP | | 6480464 | Curcumin results in increased expression of EGR1 mRNA and Curcumin results in increased expression of EGR1 protein | CTD | PMID:17198877 and PMID:18316600 |
EGR1 | Human | curcumin | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Curcumin results in increased expression of EGR1 protein | CTD | PMID:18316600 |
EGR1 | Human | curcumin | decreases expression | EXP | | 6480464 | Curcumin results in decreased expression of EGR1 mRNA | CTD | PMID:17999991 |
EGR1 | Human | cyanocob(III)alamin | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of EGR1 mRNA | CTD | PMID:33549593 |
EGR1 | Human | cycloheximide | multiple interactions | EXP | | 6480464 | Cycloheximide inhibits the reaction [resveratrol results in increased expression of EGR1 mRNA] | CTD | PMID:12690110 |
EGR1 | Human | cyclophosphamide | increases expression | EXP | | 6480464 | Cyclophosphamide results in increased expression of EGR1 mRNA | CTD | PMID:21527772 |
EGR1 | Human | cyclophosphamide | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | Cyclophosphamide results in increased expression of EGR1 protein | CTD | PMID:29129814 |
EGR1 | Human | cyclophosphamide | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | 3-cyanoalanine inhibits the reaction [[N more ... | CTD | PMID:29129814 |
EGR1 | Human | cyclophosphamide | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Cyclophosphamide results in increased expression of EGR1 protein | CTD | PMID:7498375 and PMID:9776515 |
EGR1 | Human | cyclophosphamide | decreases expression | ISO | Egr1 (Mus musculus) | 6480464 | Cyclophosphamide results in decreased expression of EGR1 mRNA | CTD | PMID:21041162 |
EGR1 | Human | cyclosporin A | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Cyclosporine results in increased expression of EGR1 mRNA | CTD | PMID:21865292 |
EGR1 | Human | cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of EGR1 mRNA | CTD | PMID:20106945 more ... |
EGR1 | Human | cylindrospermopsin | increases expression | EXP | | 6480464 | cylindrospermopsin results in increased expression of EGR1 mRNA | CTD | PMID:24921660 |
EGR1 | Human | cypermethrin | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | 1 more ... | CTD | PMID:29149324 and PMID:30974244 |
EGR1 | Human | cypermethrin | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | cypermethrin results in increased expression of EGR1 mRNA and cypermethrin results in increased expression of EGR1 protein | CTD | PMID:29149324 |
EGR1 | Human | D-cycloserine | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Cycloserine results in increased expression of EGR1 protein | CTD | PMID:19144966 |
EGR1 | Human | D-glucose | multiple interactions | EXP | | 6480464 | Glucose promotes the reaction [AGT protein results in increased expression of EGR1 mRNA] and Valsartan inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased expression of EGR1 mRNA]] | CTD | PMID:19225232 |
EGR1 | Human | D-glucose | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of EGR1 mRNA | CTD | PMID:37567420 |
EGR1 | Human | D-glucose | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | Glucose results in increased expression of EGR1 mRNA | CTD | PMID:17178593 |
EGR1 | Human | D-glucose | increases expression | EXP | | 6480464 | Glucose results in increased expression of EGR1 mRNA | CTD | PMID:19225232 |
EGR1 | Human | D-penicillamine | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Penicillamine results in increased expression of EGR1 mRNA | CTD | PMID:19575532 |
EGR1 | Human | D-penicillamine | increases expression | EXP | | 6480464 | Penicillamine results in increased expression of EGR1 mRNA | CTD | PMID:22843330 |
EGR1 | Human | DDT | decreases expression | EXP | | 6480464 | DDT results in decreased expression of EGR1 mRNA | CTD | PMID:25014179 |
EGR1 | Human | DDT | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | DDT results in increased expression of EGR1 mRNA | CTD | PMID:30207508 |
EGR1 | Human | deoxycholic acid | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | EGR1 promotes the reaction [Deoxycholic Acid results in increased expression of CCL7 mRNA] more ... | CTD | PMID:19931294 and PMID:21224055 |
EGR1 | Human | deoxycholic acid | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | Deoxycholic Acid results in increased expression of EGR1 mRNA and Deoxycholic Acid results in increased expression of EGR1 protein | CTD | PMID:19931294 and PMID:21224055 |
EGR1 | Human | deoxynivalenol | increases expression | EXP | | 6480464 | [deoxynivalenol results in increased expression of EGR1 protein] which results in increased expression of CXCL8 protein more ... | CTD | PMID:17707346 more ... |
EGR1 | Human | deoxynivalenol | multiple interactions | EXP | | 6480464 | ATF3 protein affects the reaction [deoxynivalenol results in increased expression of EGR1 protein] more ... | CTD | PMID:18485432 more ... |
EGR1 | Human | desipramine | decreases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Desipramine results in decreased expression of EGR1 mRNA | CTD | PMID:7612155 |
EGR1 | Human | dexamethasone | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | Dexamethasone promotes the reaction [1-Naphthylisothiocyanate results in increased expression of EGR1 mRNA] and Dexamethasone promotes the reaction [EGR1 protein results in increased expression of PNMT mRNA] | CTD | PMID:18590720 and PMID:8063705 |
EGR1 | Human | dexamethasone | decreases expression | ISO | Egr1 (Mus musculus) | 6480464 | Dexamethasone results in decreased expression of EGR1 mRNA | CTD | PMID:21041162 |
EGR1 | Human | diarsenic trioxide | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | Arsenic Trioxide results in increased expression of EGR1 mRNA | CTD | PMID:15073043 and PMID:15688020 |
EGR1 | Human | diarsenic trioxide | decreases expression | EXP | | 6480464 | Arsenic Trioxide results in decreased expression of EGR1 mRNA | CTD | PMID:20458559 more ... |
EGR1 | Human | diarsenic trioxide | decreases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Arsenic Trioxide results in decreased expression of EGR1 mRNA | CTD | PMID:29223816 |
EGR1 | Human | diarsenic trioxide | affects methylation | EXP | | 6480464 | Arsenic Trioxide affects the methylation of EGR1 promoter | CTD | PMID:26046465 |
EGR1 | Human | diarsenic trioxide | affects expression | EXP | | 6480464 | Arsenic Trioxide affects the expression of EGR1 mRNA | CTD | PMID:12749819 |
EGR1 | Human | diarsenic trioxide | increases expression | EXP | | 6480464 | Arsenic Trioxide results in increased expression of EGR1 mRNA | CTD | PMID:25258189 |
EGR1 | Human | diarsenic trioxide | multiple interactions | EXP | | 6480464 | [Zidovudine co-treated with Arsenic Trioxide] results in increased expression of EGR1 mRNA | CTD | PMID:29910624 |
EGR1 | Human | diarsenic trioxide | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | pyrazolanthrone inhibits the reaction [Arsenic Trioxide results in increased expression of EGR1 mRNA] and Tretinoin promotes the reaction [Arsenic Trioxide results in increased expression of EGR1 mRNA] | CTD | PMID:15688020 |
EGR1 | Human | diazinon | increases methylation | EXP | | 6480464 | Diazinon results in increased methylation of EGR1 gene | CTD | PMID:22964155 |
EGR1 | Human | dibenz[a,h]anthracene | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | 1 more ... | CTD | PMID:26377693 |
EGR1 | Human | Dibutyl phosphate | affects expression | EXP | | 6480464 | di-n-butylphosphoric acid affects the expression of EGR1 mRNA | CTD | PMID:37042841 |
EGR1 | Human | dibutyl phthalate | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | Dibutyl Phthalate results in increased expression of EGR1 mRNA | CTD | PMID:17361019 and PMID:21266533 |
EGR1 | Human | dibutyl phthalate | decreases expression | ISO | Egr1 (Mus musculus) | 6480464 | Dibutyl Phthalate results in decreased expression of EGR1 mRNA | CTD | PMID:31841868 |
EGR1 | Human | dibutyl phthalate | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of EGR1 mRNA | CTD | PMID:39150890 |
EGR1 | Human | dibutyl phthalate | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Dibutyl Phthalate results in increased expression of EGR1 mRNA | CTD | PMID:15728792 more ... |
EGR1 | Human | dichlorine | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | [Ozone co-treated with Chlorine] results in increased expression of EGR1 mRNA | CTD | PMID:18636392 |
EGR1 | Human | dichloroacetic acid | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | Dichloroacetic Acid results in increased expression of EGR1 mRNA | CTD | PMID:28962523 |
EGR1 | Human | dichloromethane | affects expression | ISO | Egr1 (Mus musculus) | 6480464 | Methylene Chloride affects the expression of EGR1 mRNA | CTD | PMID:28392392 |
EGR1 | Human | diclofenac | increases expression | EXP | | 6480464 | Diclofenac results in increased expression of EGR1 mRNA | CTD | PMID:15509713 |
EGR1 | Human | diclofenac | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | [Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in decreased expression of EGR1 mRNA | CTD | PMID:37844793 |
EGR1 | Human | diclofenac | affects expression | ISO | Egr1 (Mus musculus) | 6480464 | Diclofenac affects the expression of EGR1 mRNA | CTD | PMID:26934552 |
EGR1 | Human | dicrotophos | increases expression | EXP | | 6480464 | dicrotophos results in increased expression of EGR1 mRNA | CTD | PMID:28302478 |
EGR1 | Human | dieldrin | increases expression | EXP | | 6480464 | Dieldrin results in increased expression of EGR1 mRNA | CTD | PMID:31068361 |
EGR1 | Human | diethyl phthalate | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of EGR1 mRNA | CTD | PMID:39150890 |
EGR1 | Human | diethylstilbestrol | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | Diethylstilbestrol results in increased expression of EGR1 mRNA | CTD | PMID:16636312 |
EGR1 | Human | diethylstilbestrol | increases expression | EXP | | 6480464 | Diethylstilbestrol results in increased expression of EGR1 mRNA | CTD | PMID:36621641 |
EGR1 | Human | diethylstilbestrol | decreases expression | ISO | Egr1 (Mus musculus) | 6480464 | Diethylstilbestrol results in decreased expression of EGR1 mRNA | CTD | PMID:21041162 |
EGR1 | Human | digoxin | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | Digoxin inhibits the reaction [Ethinyl Estradiol results in increased expression of EGR1 mRNA] and Digoxin inhibits the reaction [Ethinyl Estradiol results in increased expression of EGR1 protein] | CTD | PMID:36329302 |
EGR1 | Human | dihydroartemisinin | increases expression | EXP | | 6480464 | artenimol results in increased expression of EGR1 mRNA | CTD | PMID:21547369 |
EGR1 | Human | dihydroxyacetone | affects expression | EXP | | 6480464 | Dihydroxyacetone affects the expression of EGR1 mRNA | CTD | PMID:32506039 |
EGR1 | Human | diisobutyl phthalate | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of EGR1 mRNA | CTD | PMID:39150890 |
EGR1 | Human | diisononyl phthalate | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of EGR1 mRNA | CTD | PMID:39150890 |
EGR1 | Human | dimethyl sulfoxide | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Dimethyl Sulfoxide results in increased expression of EGR1 mRNA | CTD | PMID:22193206 |
EGR1 | Human | dimethylarsinic acid | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | Cacodylic Acid results in increased expression of EGR1 mRNA | CTD | PMID:15345372 |
EGR1 | Human | dimethylarsinic acid | multiple interactions | EXP | | 6480464 | [Arsenic results in increased abundance of Cacodylic Acid] which affects the expression of EGR1 mRNA and [sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of EGR1 mRNA | CTD | PMID:23192986 and PMID:28793237 |
EGR1 | Human | dimethylarsinous acid | decreases expression | EXP | | 6480464 | dimethylarsinous acid results in decreased expression of EGR1 mRNA | CTD | PMID:23876855 |
EGR1 | Human | dinophysistoxin 1 | increases expression | EXP | | 6480464 | dinophysistoxin 1 results in increased expression of EGR1 mRNA | CTD | PMID:28939011 |
EGR1 | Human | dioxygen | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | 15-deoxy-delta(12 more ... | CTD | PMID:12468449 |
EGR1 | Human | dioxygen | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EGR1 mRNA | CTD | PMID:30529165 |
EGR1 | Human | dioxygen | increases expression | EXP | | 6480464 | Oxygen deficiency results in increased expression of EGR1 mRNA | CTD | PMID:17914565 more ... |
EGR1 | Human | dioxygen | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Oxygen deficiency results in increased expression of EGR1 mRNA | CTD | PMID:12468449 |
EGR1 | Human | diquat | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | PROP1 protein affects the reaction [Diquat results in increased expression of EGR1 mRNA] | CTD | PMID:20826540 |
EGR1 | Human | diquat | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | Diquat results in increased expression of EGR1 mRNA | CTD | PMID:20826540 |
EGR1 | Human | disodium selenite | increases expression | EXP | | 6480464 | Sodium Selenite results in increased expression of EGR1 mRNA | CTD | PMID:18175754 |
EGR1 | Human | disodium selenite | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Sodium Selenite results in increased expression of EGR1 mRNA | CTD | PMID:20067779 |
EGR1 | Human | disodium selenite | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | Acetylcarnitine inhibits the reaction [Sodium Selenite results in increased expression of EGR1 mRNA] | CTD | PMID:20067779 |
EGR1 | Human | disulfiram | multiple interactions | EXP | | 6480464 | [Disulfiram binds to Copper] which results in decreased expression of EGR1 mRNA | CTD | PMID:24690739 |
EGR1 | Human | divanadium pentaoxide | affects expression | EXP | | 6480464 | vanadium pentoxide affects the expression of EGR1 mRNA | CTD | PMID:17459161 |
EGR1 | Human | dizocilpine maleate | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | Dizocilpine Maleate inhibits the reaction [Zinc results in increased expression of EGR1 protein] | CTD | PMID:10428039 |
EGR1 | Human | donepezil hydrochloride | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | Donepezil inhibits the reaction [Scopolamine results in decreased expression of EGR1 protein] | CTD | PMID:29133030 |
EGR1 | Human | donepezil hydrochloride | multiple interactions | EXP | | 6480464 | EGR1 protein affects the reaction [Donepezil affects the expression of ICAM1 protein] | CTD | PMID:32174113 |
EGR1 | Human | donepezil hydrochloride | affects expression | EXP | | 6480464 | Donepezil affects the expression of EGR1 mRNA and Donepezil affects the expression of EGR1 protein | CTD | PMID:32174113 |
EGR1 | Human | doramapimod | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | doramapimod results in increased expression of EGR1 mRNA | CTD | PMID:21328587 |
EGR1 | Human | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 |
EGR1 | Human | doxorubicin | multiple interactions | EXP | | 6480464 | [Doxorubicin co-treated with trichostatin A] results in increased expression of EGR1 mRNA and EGR1 protein affects the susceptibility to [Doxorubicin co-treated with trichostatin A] | CTD | PMID:17330857 |
EGR1 | Human | doxorubicin | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Doxorubicin results in increased expression of EGR1 mRNA | CTD | PMID:10625299 |
EGR1 | Human | doxorubicin | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Doxorubicin results in increased expression of EGR1 mRNA] more ... | CTD | PMID:10625299 |
EGR1 | Human | doxorubicin | decreases expression | ISO | Egr1 (Mus musculus) | 6480464 | Doxorubicin results in decreased expression of EGR1 protein | CTD | PMID:12714334 |
EGR1 | Human | doxorubicin | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | [Doxorubicin co-treated with Razoxane] results in decreased expression of EGR1 protein | CTD | PMID:12714334 |
EGR1 | Human | doxorubicin | affects expression | EXP | | 6480464 | Doxorubicin affects the expression of EGR1 mRNA | CTD | PMID:15205334 |
EGR1 | Human | elemental selenium | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | [Selenium deficiency co-treated with Vitamin E deficiency] results in increased expression of EGR1 mRNA | CTD | PMID:11444866 |
EGR1 | Human | emodin | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | Emodin inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of EGR1 mRNA] | CTD | PMID:18590720 |
EGR1 | Human | endosulfan | increases expression | EXP | | 6480464 | Endosulfan results in increased expression of EGR1 mRNA | CTD | PMID:26722802 |
EGR1 | Human | endosulfan | decreases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Endosulfan results in decreased expression of EGR1 mRNA | CTD | PMID:29391264 |
EGR1 | Human | enniatin | increases expression | EXP | | 6480464 | enniatins results in increased expression of EGR1 mRNA | CTD | PMID:30227181 |
EGR1 | Human | enniatin | decreases expression | EXP | | 6480464 | enniatins results in decreased expression of EGR1 mRNA | CTD | PMID:36016515 |
EGR1 | Human | Enterolactone | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EGR1 mRNA | CTD | PMID:19167446 |
EGR1 | Human | Enterolactone | decreases expression | EXP | | 6480464 | 2 and 3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of EGR1 mRNA | CTD | PMID:19167446 |
EGR1 | Human | entinostat | decreases expression | EXP | | 6480464 | entinostat results in decreased expression of EGR1 mRNA | CTD | PMID:26272509 |
EGR1 | Human | epoxiconazole | decreases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | epoxiconazole results in decreased expression of EGR1 mRNA | CTD | PMID:28454766 |
EGR1 | Human | epoxiconazole | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | epoxiconazole results in increased expression of EGR1 mRNA | CTD | PMID:35436446 |
EGR1 | Human | estriol | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Estriol results in increased expression of EGR1 mRNA | CTD | PMID:1717835 |
EGR1 | Human | ethanol | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | Ethanol results in increased expression of EGR1 mRNA | CTD | PMID:18427989 |
EGR1 | Human | ethanol | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | EGR1 protein affects the reaction [Ethanol promotes the reaction [EGR1 protein binds to ACE promoter]] more ... | CTD | PMID:31887396 |
EGR1 | Human | ethanol | affects localization | ISO | Egr1 (Rattus norvegicus) | 6480464 | Ethanol affects the localization of EGR1 protein | CTD | PMID:31887396 |
EGR1 | Human | ethanol | affects splicing | ISO | Egr1 (Mus musculus) | 6480464 | Ethanol affects the splicing of EGR1 mRNA | CTD | PMID:30319688 |
EGR1 | Human | ethanol | affects expression | ISO | Egr1 (Mus musculus) | 6480464 | Ethanol affects the expression of EGR1 mRNA | CTD | PMID:30319688 |
EGR1 | Human | ethanol | increases expression | EXP | | 6480464 | Ethanol results in increased expression of EGR1 mRNA and Ethanol results in increased expression of EGR1 protein | CTD | PMID:29802914 |
EGR1 | Human | ethanol | increases response to substance | EXP | | 6480464 | EGR1 protein results in increased susceptibility to Ethanol | CTD | PMID:29802914 |
EGR1 | Human | ethanol | multiple interactions | EXP | | 6480464 | [[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of EGR1 mRNA more ... | CTD | PMID:29432896 and PMID:29802914 |
EGR1 | Human | ethanol | decreases expression | ISO | Egr1 (Mus musculus) | 6480464 | Ethanol results in decreased expression of EGR1 mRNA | CTD | PMID:21955143 |
EGR1 | Human | ethanol | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Ethanol results in increased expression of EGR1 mRNA and Ethanol results in increased expression of EGR1 protein | CTD | PMID:15234257 more ... |
EGR1 | Human | ethanol | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | Naltrexone promotes the reaction [Ethanol results in increased expression of EGR1 mRNA] | CTD | PMID:18427989 |
EGR1 | Human | ethyl methanesulfonate | increases expression | EXP | | 6480464 | Ethyl Methanesulfonate results in increased expression of EGR1 mRNA | CTD | PMID:23649840 |
EGR1 | Human | ethylene glycol bis(2-aminoethyl)tetraacetic acid | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | Egtazic Acid inhibits the reaction [cypermethrin results in increased expression of EGR1 protein] | CTD | PMID:29149324 |
EGR1 | Human | Ethylenethiourea | decreases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Ethylenethiourea results in decreased expression of EGR1 mRNA | CTD | PMID:27905518 |
EGR1 | Human | Ethylenethiourea | decreases expression | ISO | Egr1 (Mus musculus) | 6480464 | Ethylenethiourea results in decreased expression of EGR1 mRNA | CTD | PMID:27905518 |
EGR1 | Human | Ethylenethiourea | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | [Chlorpyrifos co-treated with Ethylenethiourea] results in decreased expression of EGR1 mRNA | CTD | PMID:27905518 |
EGR1 | Human | eticlopride(1+) | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | eticlopride inhibits the reaction [[Reserpine co-treated with Levodopa] results in increased expression of EGR1 mRNA] | CTD | PMID:9890435 |
EGR1 | Human | eticlopride(1+) | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | eticlopride results in increased expression of EGR1 mRNA | CTD | PMID:9890435 |
EGR1 | Human | eugenol | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | [[Eugenol results in increased activity of OR5D18 protein] which results in increased abundance of Cyclic AMP] which results in increased expression of EGR1 mRNA | CTD | PMID:12767924 |
EGR1 | Human | fenpyroximate | increases expression | EXP | | 6480464 | fenpyroximate results in increased expression of EGR1 mRNA | CTD | PMID:33512557 |
EGR1 | Human | fentin chloride | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | triphenyltin chloride results in increased expression of EGR1 mRNA | CTD | PMID:37156404 |
EGR1 | Human | ferric oxide | decreases expression | ISO | Egr1 (Mus musculus) | 6480464 | ferric oxide analog results in decreased expression of EGR1 mRNA | CTD | PMID:25086211 |
EGR1 | Human | flavonoids | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Flavonoids results in increased expression of EGR1 mRNA | CTD | PMID:18035473 |
EGR1 | Human | fluoranthene | increases expression | EXP | | 6480464 | fluoranthene results in increased expression of EGR1 mRNA and fluoranthene results in increased expression of EGR1 protein | CTD | PMID:15342960 and PMID:29787794 |
EGR1 | Human | fluoranthene | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | fluoranthene results in increased expression of EGR1 mRNA | CTD | PMID:28329830 |
EGR1 | Human | fluoranthene | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | [1-methylanthracene co-treated with fluoranthene] results in increased expression of EGR1 mRNA | CTD | PMID:28329830 |
EGR1 | Human | fluoxetine | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | [Fluoxetine co-treated with Methylphenidate] results in increased expression of EGR1 mRNA and Fluoxetine promotes the reaction [Methylphenidate results in increased expression of EGR1 mRNA] | CTD | PMID:19931852 and PMID:21753012 |
EGR1 | Human | fluoxetine | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Fluoxetine results in increased expression of EGR1 mRNA | CTD | PMID:21753012 |
EGR1 | Human | folic acid | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | [1 more ... | CTD | PMID:20938992 more ... |
EGR1 | Human | folic acid | multiple interactions | EXP | | 6480464 | [Folic Acid co-treated with Arsenic] affects the expression of EGR1 mRNA and Folic Acid inhibits the reaction [Arsenic results in decreased methylation of EGR1 promoter] | CTD | PMID:35490796 |
EGR1 | Human | folpet | decreases expression | ISO | Egr1 (Mus musculus) | 6480464 | folpet results in decreased expression of EGR1 mRNA | CTD | PMID:31558096 |
EGR1 | Human | formaldehyde | increases expression | EXP | | 6480464 | Formaldehyde results in increased expression of EGR1 mRNA | CTD | PMID:20655997 and PMID:28937961 |
EGR1 | Human | fructose | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of EGR1 mRNA | CTD | PMID:37567420 |
EGR1 | Human | fulvestrant | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | fulvestrant inhibits the reaction [bisphenol A results in increased expression of EGR1 mRNA] more ... | CTD | PMID:25461906 |
EGR1 | Human | furan | decreases expression | ISO | Egr1 (Mus musculus) | 6480464 | furan results in decreased expression of EGR1 mRNA | CTD | PMID:20194422 |
EGR1 | Human | gallium nitrate | increases expression | EXP | | 6480464 | gallium nitrate results in increased expression of EGR1 mRNA | CTD | PMID:18586083 |
EGR1 | Human | gamma-aminobutyric acid | decreases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | gamma-Aminobutyric Acid results in decreased expression of EGR1 mRNA | CTD | PMID:26924987 |
EGR1 | Human | gamma-hexachlorocyclohexane | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Hexachlorocyclohexane results in increased expression of EGR1 mRNA | CTD | PMID:17785943 |
EGR1 | Human | gamma-tocopherol | decreases activity | EXP | | 6480464 | Tocopherols results in decreased activity of EGR1 protein | CTD | PMID:15878867 |
EGR1 | Human | gemcitabine | increases expression | EXP | | 6480464 | Gemcitabine results in increased expression of EGR1 mRNA | CTD | PMID:17039268 |
EGR1 | Human | genistein | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Genistein results in increased expression of EGR1 mRNA | CTD | PMID:12075121 |
EGR1 | Human | genistein | increases expression | EXP | | 6480464 | Genistein results in increased expression of EGR1 mRNA | CTD | PMID:15257099 more ... |
EGR1 | Human | genistein | decreases expression | EXP | | 6480464 | Genistein results in decreased expression of EGR1 mRNA | CTD | PMID:22228119 |
EGR1 | Human | gentamycin | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Gentamicins results in increased expression of EGR1 mRNA | CTD | PMID:33387578 |
EGR1 | Human | glucose | multiple interactions | EXP | | 6480464 | Glucose promotes the reaction [AGT protein results in increased expression of EGR1 mRNA] and Valsartan inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased expression of EGR1 mRNA]] | CTD | PMID:19225232 |
EGR1 | Human | glucose | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of EGR1 mRNA | CTD | PMID:37567420 |
EGR1 | Human | glucose | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | Glucose results in increased expression of EGR1 mRNA | CTD | PMID:17178593 |
EGR1 | Human | glucose | increases expression | EXP | | 6480464 | Glucose results in increased expression of EGR1 mRNA | CTD | PMID:19225232 |
EGR1 | Human | glycine betaine | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Betaine results in increased expression of EGR1 mRNA | CTD | PMID:26391144 |
EGR1 | Human | glycine betaine | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of EGR1 mRNA | CTD | PMID:33549593 |
EGR1 | Human | glyphosate | multiple interactions | EXP | | 6480464 | Glyphosate promotes the reaction [Estradiol results in decreased expression of EGR1 mRNA] | CTD | PMID:17984146 |
EGR1 | Human | glyphosate | decreases expression | EXP | | 6480464 | Glyphosate results in decreased expression of EGR1 mRNA | CTD | PMID:17984146 |
EGR1 | Human | haloperidol | affects expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Haloperidol affects the expression of EGR1 protein | CTD | PMID:17028028 |
EGR1 | Human | haloperidol | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | Haloperidol inhibits the reaction [Methamphetamine results in increased expression of EGR1 mRNA] and OPRM1 protein inhibits the reaction [Haloperidol inhibits the reaction [Methamphetamine results in increased expression of EGR1 mRNA]] | CTD | PMID:20184921 |
EGR1 | Human | haloperidol | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Haloperidol results in increased expression of EGR1 mRNA and Haloperidol results in increased expression of EGR1 protein | CTD | PMID:12243769 more ... |
EGR1 | Human | herbicide | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of EGR1 mRNA | CTD | PMID:37567420 |
EGR1 | Human | hexadecanoic acid | increases expression | EXP | | 6480464 | Palmitic Acid results in increased expression of EGR1 mRNA | CTD | PMID:32347412 |
EGR1 | Human | hydrogen peroxide | increases expression | EXP | | 6480464 | Hydrogen Peroxide results in increased expression of EGR1 mRNA | CTD | PMID:12414654 and PMID:32949572 |
EGR1 | Human | hydrogen peroxide | affects expression | EXP | | 6480464 | Hydrogen Peroxide affects the expression of EGR1 mRNA | CTD | PMID:20044591 and PMID:23410634 |
EGR1 | Human | hydrogen peroxide | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | Hydrogen Peroxide results in increased expression of EGR1 mRNA | CTD | PMID:19786089 |
EGR1 | Human | hydrogen peroxide | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Hydrogen Peroxide results in increased expression of EGR1 mRNA] | CTD | PMID:19786089 |
EGR1 | Human | hydrogen peroxide | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Hydrogen Peroxide results in increased expression of EGR1 mRNA | CTD | PMID:10625299 |
EGR1 | Human | hydroxytyrosol | multiple interactions | EXP | | 6480464 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [3 more ... | CTD | PMID:12482581 |
EGR1 | Human | hydroxytyrosol | increases expression | EXP | | 6480464 | 3 more ... | CTD | PMID:12482581 |
EGR1 | Human | ibuprofen | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | [Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in decreased expression of EGR1 mRNA | CTD | PMID:37844793 |
EGR1 | Human | imidazopyrazole | decreases expression | EXP | | 6480464 | imidazopyrazole analog results in decreased expression of EGR1 mRNA | CTD | PMID:30388846 |
EGR1 | Human | indole-3-methanol | affects expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | indole-3-carbinol affects the expression of EGR1 mRNA | CTD | PMID:21396975 |
EGR1 | Human | indometacin | multiple interactions | EXP | | 6480464 | Indomethacin inhibits the reaction [VEGFA protein results in increased expression of EGR1 mRNA] and Indomethacin inhibits the reaction [VEGFA protein results in increased expression of EGR1 protein] | CTD | PMID:11595463 |
EGR1 | Human | indometacin | increases expression | EXP | | 6480464 | Indomethacin results in increased expression of EGR1 mRNA and Indomethacin results in increased expression of EGR1 protein | CTD | PMID:15509713 and PMID:16227405 |
EGR1 | Human | inulin | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of EGR1 mRNA | CTD | PMID:36331819 |
EGR1 | Human | ionomycin | multiple interactions | EXP | | 6480464 | [Ionomycin results in increased abundance of Calcium] which results in increased expression of EGR1 protein | CTD | PMID:12517959 |
EGR1 | Human | irinotecan | increases expression | EXP | | 6480464 | Irinotecan metabolite results in increased expression of EGR1 mRNA and Irinotecan results in increased expression of EGR1 mRNA | CTD | PMID:15956246 |
EGR1 | Human | irinotecan | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Irinotecan results in increased expression of EGR1 mRNA | CTD | PMID:16280599 and PMID:20097248 |
EGR1 | Human | iron atom | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Iron deficiency results in increased expression of EGR1 mRNA | CTD | PMID:16629162 |
EGR1 | Human | iron atom | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | [Tungsten co-treated with Nickel co-treated with Iron] results in increased expression of EGR1 mRNA | CTD | PMID:24619124 |
EGR1 | Human | iron(0) | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Iron deficiency results in increased expression of EGR1 mRNA | CTD | PMID:16629162 |
EGR1 | Human | iron(0) | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | [Tungsten co-treated with Nickel co-treated with Iron] results in increased expression of EGR1 mRNA | CTD | PMID:24619124 |
EGR1 | Human | iron(2+) sulfate (anhydrous) | decreases expression | EXP | | 6480464 | ferrous sulfate results in decreased expression of EGR1 mRNA | CTD | PMID:21540303 |
EGR1 | Human | isobutanol | multiple interactions | EXP | | 6480464 | [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of EGR1 mRNA | CTD | PMID:29432896 |
EGR1 | Human | isoprenaline | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | EGR1 protein affects the reaction [[Isoproterenol co-treated with Phenylephrine] results in increased expression of SLC8A1 mRNA] more ... | CTD | PMID:10710348 and PMID:15621046 |
EGR1 | Human | isoprenaline | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Isoproterenol results in increased expression of EGR1 protein | CTD | PMID:15621046 |
EGR1 | Human | isoprenaline | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Isoproterenol results in increased expression of EGR1 protein] more ... | CTD | PMID:15621046 |
EGR1 | Human | isoprenaline | decreases expression | ISO | Egr1 (Mus musculus) | 6480464 | Isoproterenol results in decreased expression of EGR1 mRNA | CTD | PMID:20003209 |
EGR1 | Human | juglone | multiple interactions | EXP | | 6480464 | juglone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of EGR1 protein] | CTD | PMID:20479004 |
EGR1 | Human | kainic acid | decreases expression | ISO | Egr1 (Mus musculus) | 6480464 | Kainic Acid results in decreased expression of EGR1 mRNA | CTD | PMID:17997037 |
EGR1 | Human | kainic acid | affects expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Kainic Acid affects the expression of EGR1 mRNA | CTD | PMID:19700661 |
EGR1 | Human | kojic acid | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in increased expression of EGR1 mRNA | CTD | PMID:18544905 |
EGR1 | Human | L-methionine | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of EGR1 mRNA and [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of EGR1 gene | CTD | PMID:20938992 and PMID:33549593 |
EGR1 | Human | lanthanum atom | decreases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Lanthanum results in decreased expression of EGR1 mRNA | CTD | PMID:21695898 |
EGR1 | Human | lanthanum trichloride | decreases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | lanthanum chloride results in decreased expression of EGR1 mRNA and lanthanum chloride results in decreased expression of EGR1 protein | CTD | PMID:19643171 and PMID:21624330 |
EGR1 | Human | lead diacetate | decreases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | lead acetate results in decreased expression of EGR1 mRNA | CTD | PMID:22641619 |
EGR1 | Human | lead diacetate | increases expression | EXP | | 6480464 | lead acetate results in increased expression of EGR1 mRNA | CTD | PMID:38568856 |
EGR1 | Human | lead(0) | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Lead results in increased expression of EGR1 mRNA | CTD | PMID:10693946 |
EGR1 | Human | lead(0) | increases activity | ISO | Egr1 (Rattus norvegicus) | 6480464 | Lead results in increased activity of EGR1 protein | CTD | PMID:10693946 |
EGR1 | Human | leflunomide | increases expression | EXP | | 6480464 | leflunomide results in increased expression of EGR1 mRNA | CTD | PMID:28988120 |
EGR1 | Human | Licochalcone B | increases expression | EXP | | 6480464 | licochalcone B results in increased expression of EGR1 mRNA | CTD | PMID:33647349 |
EGR1 | Human | lidocaine | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Lidocaine results in increased expression of EGR1 mRNA | CTD | PMID:35283115 |
EGR1 | Human | lipopolysaccharide | decreases expression | ISO | Egr1 (Mus musculus) | 6480464 | Lipopolysaccharides results in decreased expression of EGR1 mRNA | CTD | PMID:27339419 |
EGR1 | Human | lipopolysaccharide | affects localization | ISO | Egr1 (Mus musculus) | 6480464 | Lipopolysaccharides affects the localization of EGR1 protein | CTD | PMID:25451575 |
EGR1 | Human | lipopolysaccharide | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | 3 more ... | CTD | PMID:22046279 more ... |
EGR1 | Human | lipopolysaccharide | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | [Lipopolysaccharides co-treated with Ranitidine] results in increased expression of EGR1 mRNA and Ranitidine promotes the reaction [Lipopolysaccharides results in increased expression of EGR1 mRNA] | CTD | PMID:16401727 and PMID:16415329 |
EGR1 | Human | lipopolysaccharide | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Lipopolysaccharides results in increased expression of EGR1 mRNA | CTD | PMID:16415329 |
EGR1 | Human | lipopolysaccharide | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | Lipopolysaccharides results in increased expression of EGR1 mRNA and Lipopolysaccharides results in increased expression of EGR1 protein | CTD | PMID:10975854 more ... |
EGR1 | Human | luteolin | increases expression | EXP | | 6480464 | Luteolin results in increased expression of EGR1 mRNA | CTD | PMID:19397994 |
EGR1 | Human | maneb | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | [Maneb co-treated with Paraquat] results in decreased expression of EGR1 mRNA | CTD | PMID:36117858 |
EGR1 | Human | manganese atom | multiple interactions | EXP | | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of EGR1 mRNA and [manganese chloride results in increased abundance of Manganese] which results in decreased expression of EGR1 mRNA | CTD | PMID:39836092 |
EGR1 | Human | manganese(0) | multiple interactions | EXP | | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of EGR1 mRNA and [manganese chloride results in increased abundance of Manganese] which results in decreased expression of EGR1 mRNA | CTD | PMID:39836092 |
EGR1 | Human | manganese(II) chloride | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | manganese chloride results in increased expression of EGR1 mRNA | CTD | PMID:28801915 |
EGR1 | Human | manganese(II) chloride | multiple interactions | EXP | | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of EGR1 mRNA and [manganese chloride results in increased abundance of Manganese] which results in decreased expression of EGR1 mRNA | CTD | PMID:39836092 |
EGR1 | Human | manganese(II) chloride | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | manganese chloride results in increased expression of EGR1 mRNA | CTD | PMID:28801915 |
EGR1 | Human | MeIQx | decreases expression | EXP | | 6480464 | 2-amino-3 more ... | CTD | PMID:20816883 |
EGR1 | Human | menadione | increases expression | EXP | | 6480464 | Vitamin K 3 results in increased expression of EGR1 mRNA | CTD | PMID:12414654 |
EGR1 | Human | menadione | affects expression | EXP | | 6480464 | Vitamin K 3 affects the expression of EGR1 mRNA | CTD | PMID:20044591 and PMID:23410634 |
EGR1 | Human | mercury dichloride | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Mercuric Chloride results in increased expression of EGR1 mRNA | CTD | PMID:16507785 |
EGR1 | Human | metformin | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Metformin results in increased expression of EGR1 mRNA | CTD | PMID:19664596 and PMID:31324951 |
EGR1 | Human | methamphetamine | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | CTAP octapeptide inhibits the reaction [Methamphetamine results in increased expression of EGR1 mRNA] | CTD | PMID:20298714 |
EGR1 | Human | methamphetamine | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Methamphetamine results in increased expression of EGR1 mRNA | CTD | PMID:11754491 more ... |
EGR1 | Human | methamphetamine | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | Methamphetamine results in increased expression of EGR1 mRNA | CTD | PMID:20184921 |
EGR1 | Human | methamphetamine | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | Haloperidol inhibits the reaction [Methamphetamine results in increased expression of EGR1 mRNA] and OPRM1 protein inhibits the reaction [Haloperidol inhibits the reaction [Methamphetamine results in increased expression of EGR1 mRNA]] | CTD | PMID:20184921 |
EGR1 | Human | methotrexate | affects expression | ISO | Egr1 (Mus musculus) | 6480464 | Methotrexate affects the expression of EGR1 mRNA | CTD | PMID:18502557 |
EGR1 | Human | methotrexate | decreases expression | EXP | | 6480464 | Methotrexate results in decreased expression of EGR1 mRNA | CTD | PMID:24449571 |
EGR1 | Human | methyl methanesulfonate | increases expression | EXP | | 6480464 | Methyl Methanesulfonate results in increased expression of EGR1 mRNA | CTD | PMID:21527772 and PMID:23649840 |
EGR1 | Human | methylarsonic acid | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | monomethylarsonic acid results in increased expression of EGR1 mRNA | CTD | PMID:15345372 |
EGR1 | Human | methylarsonic acid | multiple interactions | EXP | | 6480464 | [sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of EGR1 mRNA | CTD | PMID:23192986 |
EGR1 | Human | methylisothiazolinone | increases expression | EXP | | 6480464 | 2-methyl-4-isothiazolin-3-one results in increased expression of EGR1 mRNA | CTD | PMID:31629900 |
EGR1 | Human | methylmercury chloride | increases expression | EXP | | 6480464 | methylmercuric chloride results in increased expression of EGR1 mRNA | CTD | PMID:23179753 more ... |
EGR1 | Human | methylmercury chloride | decreases expression | ISO | Egr1 (Mus musculus) | 6480464 | methylmercuric chloride results in decreased expression of EGR1 mRNA | CTD | PMID:29261810 |
EGR1 | Human | methylmercury chloride | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EGR1 mRNA | CTD | PMID:27188386 |
EGR1 | Human | methylmercury(1+) | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | [Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in decreased expression of EGR1 mRNA | CTD | PMID:17905399 |
EGR1 | Human | methylparaben | decreases expression | EXP | | 6480464 | methylparaben results in decreased expression of EGR1 mRNA | CTD | PMID:31745603 |
EGR1 | Human | methylparaben | increases expression | EXP | | 6480464 | methylparaben results in increased expression of EGR1 mRNA | CTD | PMID:38568856 |
EGR1 | Human | methylphenidate | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | [Fluoxetine co-treated with Methylphenidate] results in increased expression of EGR1 mRNA more ... | CTD | PMID:16549270 more ... |
EGR1 | Human | methylphenidate | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Methylphenidate results in increased expression of EGR1 mRNA | CTD | PMID:16549270 more ... |
EGR1 | Human | methylseleninic acid | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | methylselenic acid results in increased expression of EGR1 mRNA | CTD | PMID:11172735 |
EGR1 | Human | miconazole | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | Miconazole results in increased expression of EGR1 mRNA | CTD | PMID:27462272 |
EGR1 | Human | microcystin-LR | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | cyanoginosin LR results in increased expression of EGR1 mRNA | CTD | PMID:17383702 |
EGR1 | Human | mifepristone | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | Mifepristone inhibits the reaction [Progesterone inhibits the reaction [bisphenol A results in increased expression of EGR1 mRNA]] and Mifepristone inhibits the reaction [Progesterone inhibits the reaction [Estradiol results in increased expression of EGR1 mRNA]] | CTD | PMID:25461906 |
EGR1 | Human | mitomycin C | affects response to substance | EXP | | 6480464 | EGR1 protein affects the susceptibility to Mitomycin | CTD | PMID:16217747 |
EGR1 | Human | mitomycin C | increases expression | EXP | | 6480464 | Mitomycin results in increased expression of EGR1 mRNA | CTD | PMID:12760830 |
EGR1 | Human | mitoxantrone | affects response to substance | EXP | | 6480464 | EGR1 protein affects the susceptibility to Mitoxantrone | CTD | PMID:16217747 |
EGR1 | Human | mono(2-ethylhexyl) phthalate | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | mono-(2-ethylhexyl)phthalate results in increased expression of EGR1 mRNA | CTD | PMID:16809437 |
EGR1 | Human | mono(2-ethylhexyl) phthalate | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of EGR1 mRNA | CTD | PMID:36189433 |
EGR1 | Human | mono(2-ethylhexyl) phthalate | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | mono-(2-ethylhexyl)phthalate results in increased expression of EGR1 mRNA | CTD | PMID:8764118 |
EGR1 | Human | monocrotaline | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of EGR1 mRNA | CTD | PMID:21224054 |
EGR1 | Human | morphine | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | Morphine deficiency results in increased expression of EGR1 mRNA and Morphine results in increased expression of EGR1 mRNA | CTD | PMID:21955143 and PMID:27126842 |
EGR1 | Human | morphine | increases expression | ISO | Egr1 (Rattus norvegicus) | 401959617 | Morphine increases expression of Egr1 mRNA in ventral tegmental area and prefrontal cortex | RGD | |
EGR1 | Human | Muraglitazar | decreases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | muraglitazar results in decreased expression of EGR1 mRNA | CTD | PMID:21515302 |
EGR1 | Human | N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | 3-cyanoalanine inhibits the reaction [[N more ... | CTD | PMID:29129814 |
EGR1 | Human | N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Isoproterenol results in increased expression of EGR1 protein] more ... | CTD | PMID:15621046 and PMID:22174042 |
EGR1 | Human | N-acetyl-L-cysteine | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of EGR1 mRNA] and Acetylcysteine inhibits the reaction [Doxorubicin results in increased expression of EGR1 mRNA] | CTD | PMID:10625299 and PMID:19010381 |
EGR1 | Human | N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [platycodin D results in increased expression of EGR1 mRNA] | CTD | PMID:18804340 |
EGR1 | Human | N-methyl-4-phenylpyridinium | decreases expression | ISO | Egr1 (Mus musculus) | 6480464 | 1-Methyl-4-phenylpyridinium results in decreased expression of EGR1 mRNA | CTD | PMID:17475336 |
EGR1 | Human | N-methyl-4-phenylpyridinium | increases methylation | ISO | Egr1 (Rattus norvegicus) | 6480464 | 1-Methyl-4-phenylpyridinium results in increased methylation of EGR1 gene | CTD | PMID:28801915 |
EGR1 | Human | N-methyl-4-phenylpyridinium | decreases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | 1-Methyl-4-phenylpyridinium results in decreased expression of EGR1 mRNA | CTD | PMID:28801915 |
EGR1 | Human | N-methyl-4-phenylpyridinium | decreases expression | EXP | | 6480464 | 1-Methyl-4-phenylpyridinium results in decreased expression of EGR1 mRNA | CTD | PMID:25234470 |
EGR1 | Human | N-methyl-N'-nitro-N-nitrosoguanidine | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of EGR1 mRNA | CTD | PMID:19840844 |
EGR1 | Human | N-nitrosodiethylamine | increases expression | EXP | | 6480464 | Diethylnitrosamine results in increased expression of EGR1 mRNA | CTD | PMID:21527772 |
EGR1 | Human | N-nitrosodiethylamine | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | Diethylnitrosamine results in increased expression of EGR1 mRNA | CTD | PMID:17854601 and PMID:24535843 |
EGR1 | Human | N-nitrosodiethylamine | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of EGR1 mRNA] | CTD | PMID:17854601 |
EGR1 | Human | N-nitrosodiethylamine | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Diethylnitrosamine results in increased expression of EGR1 mRNA | CTD | PMID:19638242 |
EGR1 | Human | N-nitrosodiethylamine | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of EGR1 mRNA and [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in increased expression of EGR1 mRNA | CTD | PMID:18164116 and PMID:18544905 |
EGR1 | Human | N-nitrosomorpholine | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | N-nitrosomorpholine results in increased expression of EGR1 mRNA | CTD | PMID:19716841 |
EGR1 | Human | N-Nitrosopyrrolidine | increases expression | EXP | | 6480464 | N-Nitrosopyrrolidine results in increased expression of EGR1 mRNA | CTD | PMID:32234424 |
EGR1 | Human | N1'-[2-[[5-[(dimethylamino)methyl]-2-furanyl]methylthio]ethyl]-N1-methyl-2-nitroethene-1,1-diamine | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | [Lipopolysaccharides co-treated with Ranitidine] results in increased expression of EGR1 mRNA and Ranitidine promotes the reaction [Lipopolysaccharides results in increased expression of EGR1 mRNA] | CTD | PMID:16401727 and PMID:16415329 |
EGR1 | Human | naltrexone | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | Naltrexone promotes the reaction [Ethanol results in increased expression of EGR1 mRNA] | CTD | PMID:18427989 |
EGR1 | Human | naltrexone | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | Naltrexone results in increased expression of EGR1 mRNA | CTD | PMID:18427989 |
EGR1 | Human | nickel atom | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | [Tungsten co-treated with Nickel co-treated with Cobalt] results in increased expression of EGR1 mRNA and [Tungsten co-treated with Nickel co-treated with Iron] results in increased expression of EGR1 mRNA | CTD | PMID:24619124 |
EGR1 | Human | nickel dichloride | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | nickel chloride results in increased expression of EGR1 mRNA | CTD | PMID:24619124 |
EGR1 | Human | nickel subsulfide | decreases expression | EXP | | 6480464 | nickel subsulfide results in decreased expression of EGR1 mRNA | CTD | PMID:12760830 |
EGR1 | Human | nickel sulfate | increases expression | EXP | | 6480464 | nickel sulfate results in increased expression of EGR1 mRNA | CTD | PMID:16780908 |
EGR1 | Human | niclosamide | increases expression | EXP | | 6480464 | Niclosamide results in increased expression of EGR1 mRNA | CTD | PMID:28284560 |
EGR1 | Human | niclosamide | decreases expression | EXP | | 6480464 | Niclosamide results in decreased expression of EGR1 mRNA | CTD | PMID:36318118 |
EGR1 | Human | nicotine | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | Nicotine results in increased expression of EGR1 mRNA and Nicotine results in increased expression of EGR1 protein | CTD | PMID:17456735 and PMID:31622651 |
EGR1 | Human | nicotine | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Nicotine results in increased expression of EGR1 mRNA and Nicotine results in increased expression of EGR1 protein | CTD | PMID:29486207 and PMID:31622651 |
EGR1 | Human | nicotine | multiple interactions | EXP | | 6480464 | [triethyl-(beta-4-stilbenoxyethyl)ammonium inhibits the reaction [Nicotine promotes the reaction [EGR1 protein binds to FGF2 promoter]]] which results in decreased expression of FGF2 mRNA more ... | CTD | PMID:22198237 and PMID:29486207 |
EGR1 | Human | nicotine | increases expression | EXP | | 6480464 | Nicotine results in increased expression of EGR1 mRNA and Nicotine results in increased expression of EGR1 protein | CTD | PMID:22198237 and PMID:29486207 |
EGR1 | Human | nicotine | decreases expression | ISO | Egr1 (Mus musculus) | 6480464 | Nicotine results in decreased expression of EGR1 mRNA | CTD | PMID:17997037 and PMID:21955143 |
EGR1 | Human | nicotine | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | [Nicotine co-treated with 1-Methyl-4-phenyl-1 more ... | CTD | PMID:20230807 |
EGR1 | Human | nimodipine | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | Nimodipine inhibits the reaction [Zinc results in increased expression of EGR1 protein] | CTD | PMID:10428039 |
EGR1 | Human | nitrofen | decreases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | nitrofen results in decreased expression of EGR1 mRNA | CTD | PMID:20638522 |
EGR1 | Human | Norbinaltorphimine | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | norbinaltorphimine results in increased expression of EGR1 mRNA | CTD | PMID:18427989 |
EGR1 | Human | NS-398 | multiple interactions | EXP | | 6480464 | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [VEGFA protein results in increased expression of EGR1 mRNA] and N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [VEGFA protein results in increased expression of EGR1 protein] | CTD | PMID:11595463 |
EGR1 | Human | O-acetyl-L-carnitine | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | Acetylcarnitine inhibits the reaction [Sodium Selenite results in increased expression of EGR1 mRNA] | CTD | PMID:20067779 |
EGR1 | Human | O-methyleugenol | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | methyleugenol results in increased expression of EGR1 mRNA | CTD | PMID:15618236 |
EGR1 | Human | okadaic acid | increases expression | EXP | | 6480464 | Okadaic Acid results in increased expression of EGR1 mRNA | CTD | PMID:28939011 |
EGR1 | Human | orotic acid | decreases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Orotic Acid results in decreased expression of EGR1 mRNA | CTD | PMID:17203948 |
EGR1 | Human | orphenadrine | affects expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Orphenadrine affects the expression of EGR1 mRNA | CTD | PMID:23665939 |
EGR1 | Human | oxaliplatin | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of EGR1 mRNA | CTD | PMID:25729387 |
EGR1 | Human | oxazepam | decreases expression | ISO | Egr1 (Mus musculus) | 6480464 | Oxazepam results in decreased expression of EGR1 mRNA | CTD | PMID:15618236 |
EGR1 | Human | oxidopamine | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | [Oxidopamine co-treated with Levodopa] results in increased expression of EGR1 mRNA | CTD | PMID:9890435 |
EGR1 | Human | oxybenzone | decreases expression | ISO | Egr1 (Mus musculus) | 6480464 | oxybenzone results in decreased expression of EGR1 mRNA | CTD | PMID:39343157 |
EGR1 | Human | ozone | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | [Ozone co-treated with Chlorine] results in increased expression of EGR1 mRNA | CTD | PMID:18636392 |
EGR1 | Human | ozone | multiple interactions | EXP | | 6480464 | [Air Pollutants results in increased abundance of Ozone] which affects the expression of EGR1 mRNA | CTD | PMID:35430440 |
EGR1 | Human | ozone | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Ozone results in increased expression of EGR1 mRNA | CTD | PMID:16716893 and PMID:28623178 |
EGR1 | Human | p-chloromercuribenzoic acid | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EGR1 mRNA | CTD | PMID:27188386 |
EGR1 | Human | paracetamol | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of EGR1 mRNA more ... | CTD | PMID:12540782 more ... |
EGR1 | Human | paracetamol | affects response to substance | ISO | Egr1 (Mus musculus) | 6480464 | EGR1 protein affects the susceptibility to Acetaminophen | CTD | PMID:28286204 |
EGR1 | Human | paracetamol | multiple interactions | EXP | | 6480464 | Acetaminophen results in increased expression of and affects the localization of EGR1 protein more ... | CTD | PMID:27720869 |
EGR1 | Human | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of EGR1 mRNA | CTD | PMID:27761495 |
EGR1 | Human | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of EGR1 mRNA | CTD | PMID:21420995 more ... |
EGR1 | Human | paracetamol | affects expression | ISO | Egr1 (Mus musculus) | 6480464 | Acetaminophen affects the expression of EGR1 mRNA | CTD | PMID:15606129 and PMID:17562736 |
EGR1 | Human | paracetamol | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Acetaminophen results in increased expression of EGR1 mRNA | CTD | PMID:17202762 and PMID:33387578 |
EGR1 | Human | paracetamol | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | Acetaminophen results in increased expression of EGR1 mRNA | CTD | PMID:11752693 more ... |
EGR1 | Human | paraquat | increases expression | EXP | | 6480464 | Paraquat results in increased expression of EGR1 mRNA | CTD | PMID:20883675 |
EGR1 | Human | paraquat | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | [Maneb co-treated with Paraquat] results in decreased expression of EGR1 mRNA | CTD | PMID:36117858 |
EGR1 | Human | PD 0325901 | decreases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | mirdametinib results in decreased expression of EGR1 mRNA | CTD | PMID:21976371 |
EGR1 | Human | PD 0325901 | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | mirdametinib inhibits the reaction [camostat results in increased expression of EGR1 mRNA] | CTD | PMID:25104499 |
EGR1 | Human | pentanal | increases expression | EXP | | 6480464 | pentanal results in increased expression of EGR1 mRNA | CTD | PMID:26079696 |
EGR1 | Human | perfluorohexanesulfonic acid | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | perfluorohexanesulfonic acid results in increased expression of EGR1 mRNA | CTD | PMID:37315490 and PMID:37995155 |
EGR1 | Human | perfluorooctane-1-sulfonic acid | increases expression | EXP | | 6480464 | perfluorooctane sulfonic acid results in increased expression of EGR1 mRNA | CTD | PMID:27153767 |
EGR1 | Human | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of EGR1 mRNA more ... | CTD | PMID:36331819 |
EGR1 | Human | perfluorooctane-1-sulfonic acid | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | perfluorooctane sulfonic acid results in increased expression of EGR1 mRNA | CTD | PMID:27153767 |
EGR1 | Human | perfluorooctanoic acid | increases expression | EXP | | 6480464 | perfluorooctanoic acid results in increased expression of EGR1 mRNA | CTD | PMID:25868421 |
EGR1 | Human | perfluorooctanoic acid | decreases expression | EXP | | 6480464 | perfluorooctanoic acid results in decreased expression of EGR1 mRNA | CTD | PMID:37302725 |
EGR1 | Human | perfluorooctanoic acid | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of EGR1 mRNA | CTD | PMID:35163327 |
EGR1 | Human | perfluorooctanoic acid | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | perfluorooctanoic acid results in increased expression of EGR1 mRNA | CTD | PMID:27153767 |
EGR1 | Human | permethrin | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Permethrin results in increased expression of EGR1 mRNA | CTD | PMID:19017407 |
EGR1 | Human | phenanthrene | increases expression | EXP | | 6480464 | phenanthrene results in increased expression of EGR1 protein | CTD | PMID:15342960 |
EGR1 | Human | phenethyl isothiocyanate | increases expression | EXP | | 6480464 | phenethyl isothiocyanate results in increased expression of EGR1 mRNA | CTD | PMID:26678675 |
EGR1 | Human | phenformin | decreases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Phenformin results in decreased expression of EGR1 mRNA | CTD | PMID:31324951 |
EGR1 | Human | phenobarbital | decreases expression | ISO | Egr1 (Mus musculus) | 6480464 | Phenobarbital results in decreased expression of EGR1 mRNA | CTD | PMID:19270015 more ... |
EGR1 | Human | phenylephrine | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | EGR1 protein affects the reaction [[Isoproterenol co-treated with Phenylephrine] results in increased expression of SLC8A1 mRNA] more ... | CTD | PMID:10710348 and PMID:15621046 |
EGR1 | Human | phenylephrine | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Phenylephrine results in increased expression of EGR1 and Phenylephrine results in increased expression of EGR1 mRNA | CTD | PMID:10779383 and PMID:7905536 |
EGR1 | Human | phenylephrine | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | Phenylephrine promotes the reaction [EGR1 protein binds to FGF2 promoter] | CTD | PMID:10779383 |
EGR1 | Human | phenytoin | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of EGR1 mRNA | CTD | PMID:21224054 |
EGR1 | Human | PhIP | increases expression | EXP | | 6480464 | 2-amino-1-methyl-6-phenylimidazo(4 and 5-b)pyridine results in increased expression of EGR1 mRNA | CTD | PMID:20816883 |
EGR1 | Human | phorbol 13-acetate 12-myristate | multiple interactions | EXP | | 6480464 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of EGR1 protein] more ... | CTD | PMID:20479004 and PMID:23715767 |
EGR1 | Human | phorbol 13-acetate 12-myristate | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of EGR1 mRNA | CTD | PMID:15920718 and PMID:19945525 |
EGR1 | Human | phorbol 13-acetate 12-myristate | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of EGR1 mRNA | CTD | PMID:10693946 and PMID:2005087 |
EGR1 | Human | phorbol 13-acetate 12-myristate | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | Tetradecanoylphorbol Acetate inhibits the reaction [Carbachol results in increased expression of EGR1 mRNA] and Tetradecanoylphorbol Acetate promotes the reaction [EGR1 protein binds to FGF2 promoter] | CTD | PMID:10779383 and PMID:2005087 |
EGR1 | Human | phorbol 13-acetate 12-myristate | increases expression | EXP | | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of EGR1 mRNA and Tetradecanoylphorbol Acetate results in increased expression of EGR1 protein | CTD | PMID:10739673 more ... |
EGR1 | Human | phosgene | affects expression | ISO | Egr1 (Mus musculus) | 6480464 | Phosgene affects the expression of EGR1 mRNA | CTD | PMID:16300373 |
EGR1 | Human | pirenzepine | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | Pirenzepine inhibits the reaction [Pilocarpine results in increased expression of EGR1 mRNA] | CTD | PMID:7968354 |
EGR1 | Human | pirinixic acid | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | pirinixic acid results in increased expression of EGR1 mRNA | CTD | PMID:19162173 |
EGR1 | Human | pirinixic acid | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | pirinixic acid results in increased expression of EGR1 mRNA | CTD | PMID:8764118 |
EGR1 | Human | pirinixic acid | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of EGR1 mRNA more ... | CTD | PMID:19710929 and PMID:27853831 |
EGR1 | Human | platycodin D | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [platycodin D results in increased expression of EGR1 mRNA] | CTD | PMID:18804340 |
EGR1 | Human | platycodin D | increases expression | EXP | | 6480464 | platycodin D results in increased expression of EGR1 mRNA | CTD | PMID:18804340 |
EGR1 | Human | poly(I:C) | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | [Poly I-C results in increased susceptibility to 4-iodo-2 more ... | CTD | PMID:24889602 |
EGR1 | Human | poly(I:C) | affects methylation | ISO | Egr1 (Rattus norvegicus) | 6480464 | Poly I-C affects the methylation of EGR1 promoter | CTD | PMID:32843831 |
EGR1 | Human | potassium atom | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Potassium results in increased expression of EGR1 mRNA | CTD | PMID:10693946 |
EGR1 | Human | potassium chromate | multiple interactions | EXP | | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of EGR1 mRNA and epigallocatechin gallate inhibits the reaction [potassium chromate(VI) results in increased expression of EGR1 mRNA] | CTD | PMID:22079256 |
EGR1 | Human | potassium chromate | increases expression | EXP | | 6480464 | potassium chromate(VI) results in increased expression of EGR1 mRNA | CTD | PMID:22079256 |
EGR1 | Human | potassium cyanide | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | Potassium Cyanide inhibits the reaction [Adenosine Triphosphate results in increased expression of EGR1 mRNA] | CTD | PMID:10723097 |
EGR1 | Human | potassium cyanide | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Potassium Cyanide results in increased expression of EGR1 mRNA | CTD | PMID:10723097 |
EGR1 | Human | potassium dichromate | increases expression | EXP | | 6480464 | Potassium Dichromate results in increased expression of EGR1 mRNA | CTD | PMID:18332044 |
EGR1 | Human | pregnenolone 16alpha-carbonitrile | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Pregnenolone Carbonitrile results in increased expression of EGR1 mRNA | CTD | PMID:19162173 |
EGR1 | Human | progesterone | multiple interactions | EXP | | 6480464 | [Progesterone co-treated with Estradiol] results in decreased expression of EGR1 mRNA | CTD | PMID:17404688 |
EGR1 | Human | progesterone | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | Mifepristone inhibits the reaction [Progesterone inhibits the reaction [bisphenol A results in increased expression of EGR1 mRNA]] more ... | CTD | PMID:25461906 |
EGR1 | Human | progesterone | decreases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Progesterone results in decreased expression of EGR1 mRNA | CTD | PMID:20726854 |
EGR1 | Human | progesterone | increases expression | EXP | | 6480464 | Progesterone results in increased expression of EGR1 mRNA | CTD | PMID:21795739 |
EGR1 | Human | progesterone | affects expression | EXP | | 6480464 | Progesterone affects the expression of EGR1 mRNA | CTD | PMID:23461915 |
EGR1 | Human | propan-2-ol | increases expression | EXP | | 6480464 | 2-Propanol results in increased expression of EGR1 mRNA | CTD | PMID:37149095 |
EGR1 | Human | propiconazole | decreases expression | ISO | Egr1 (Mus musculus) | 6480464 | propiconazole results in decreased expression of EGR1 mRNA | CTD | PMID:21278054 |
EGR1 | Human | propranolol | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | Propranolol inhibits the reaction [Isoproterenol results in increased expression of EGR1 protein] | CTD | PMID:15621046 |
EGR1 | Human | propylparaben | increases expression | EXP | | 6480464 | propylparaben results in increased expression of EGR1 mRNA | CTD | PMID:38568856 |
EGR1 | Human | protein kinase inhibitor | decreases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Protein Kinase Inhibitors results in decreased expression of EGR1 mRNA | CTD | PMID:21976371 |
EGR1 | Human | pyrrolidine dithiocarbamate | multiple interactions | EXP | | 6480464 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [pyrrolidine dithiocarbamic acid results in increased expression of EGR1 mRNA] and SB 203580 promotes the reaction [pyrrolidine dithiocarbamic acid results in increased expression of EGR1 mRNA] | CTD | PMID:12482581 |
EGR1 | Human | pyrrolidine dithiocarbamate | increases expression | EXP | | 6480464 | pyrrolidine dithiocarbamic acid results in increased expression of EGR1 mRNA | CTD | PMID:12482581 |
EGR1 | Human | quartz | decreases expression | EXP | | 6480464 | Quartz results in decreased expression of EGR1 mRNA | CTD | PMID:27917503 |
EGR1 | Human | quercetin | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Quercetin results in increased expression of EGR1 mRNA] more ... | CTD | PMID:19798679 and PMID:22174042 |
EGR1 | Human | quercetin | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Quercetin results in increased expression of EGR1 mRNA and Quercetin results in increased expression of EGR1 protein | CTD | PMID:19798679 and PMID:22174042 |
EGR1 | Human | quercetin | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | Quercetin results in increased expression of EGR1 protein | CTD | PMID:22174042 |
EGR1 | Human | quercetin | increases expression | EXP | | 6480464 | Quercetin metabolite results in increased expression of EGR1 mRNA and Quercetin results in increased expression of EGR1 mRNA | CTD | PMID:21632981 more ... |
EGR1 | Human | quercetin | decreases expression | EXP | | 6480464 | Quercetin results in decreased expression of EGR1 mRNA | CTD | PMID:15309432 |
EGR1 | Human | quinolin-8-ol | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | [cupric acetate co-treated with Oxyquinoline] results in increased expression of EGR1 mRNA | CTD | PMID:10487485 |
EGR1 | Human | quinpirole | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | Quinpirole inhibits the reaction [Reserpine results in increased expression of EGR1 mRNA] | CTD | PMID:9729266 |
EGR1 | Human | raloxifene | multiple interactions | EXP | | 6480464 | [Raloxifene Hydrochloride co-treated with ESR2 protein] results in increased expression of EGR1 mRNA | CTD | PMID:19059307 |
EGR1 | Human | ranitidine | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | [Lipopolysaccharides co-treated with Ranitidine] results in increased expression of EGR1 mRNA and Ranitidine promotes the reaction [Lipopolysaccharides results in increased expression of EGR1 mRNA] | CTD | PMID:16401727 and PMID:16415329 |
EGR1 | Human | razoxane | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | [Doxorubicin co-treated with Razoxane] results in decreased expression of EGR1 protein | CTD | PMID:12714334 |
EGR1 | Human | razoxane | decreases expression | ISO | Egr1 (Mus musculus) | 6480464 | Razoxane results in decreased expression of EGR1 protein | CTD | PMID:12714334 |
EGR1 | Human | reactive oxygen species | multiple interactions | EXP | | 6480464 | [CXCR3 protein results in increased expression of EGR1] which results in increased abundance of Reactive Oxygen Species more ... | CTD | PMID:12517959 and PMID:23660334 |
EGR1 | Human | reactive oxygen species | increases activity | EXP | | 6480464 | Reactive Oxygen Species results in increased activity of EGR1 protein | CTD | PMID:23660334 |
EGR1 | Human | reactive oxygen species | affects expression | EXP | | 6480464 | Reactive Oxygen Species affects the expression of EGR1 mRNA | CTD | PMID:25800948 |
EGR1 | Human | reserpine | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | [Reserpine co-treated with Levodopa] results in increased expression of EGR1 mRNA more ... | CTD | PMID:1347779 more ... |
EGR1 | Human | reserpine | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Reserpine results in increased expression of EGR1 mRNA and Reserpine results in increased expression of EGR1 protein | CTD | PMID:8063705 and PMID:9729266 |
EGR1 | Human | resveratrol | affects expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | resveratrol affects the expression of EGR1 mRNA | CTD | PMID:21736731 |
EGR1 | Human | resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of EGR1 mRNA and resveratrol results in increased expression of EGR1 protein | CTD | PMID:12482581 more ... |
EGR1 | Human | resveratrol | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | resveratrol results in increased expression of EGR1 mRNA | CTD | PMID:16081268 |
EGR1 | Human | resveratrol | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | resveratrol results in increased expression of EGR1 mRNA | CTD | PMID:16280599 |
EGR1 | Human | resveratrol | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | resveratrol inhibits the reaction [TNF protein results in increased expression of EGR1 mRNA] | CTD | PMID:21736731 |
EGR1 | Human | resveratrol | affects response to substance | EXP | | 6480464 | EGR1 protein affects the susceptibility to resveratrol | CTD | PMID:12690110 |
EGR1 | Human | resveratrol | affects localization | EXP | | 6480464 | resveratrol affects the localization of EGR1 protein | CTD | PMID:12690110 |
EGR1 | Human | resveratrol | multiple interactions | EXP | | 6480464 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Resveratrol results in increased expression of and results in increased activity of EGR1 protein] more ... | CTD | PMID:12482581 more ... |
EGR1 | Human | riddelliine | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | riddelliine results in increased expression of EGR1 mRNA | CTD | PMID:18047727 |
EGR1 | Human | rifampicin | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of EGR1 mRNA | CTD | PMID:21224054 |
EGR1 | Human | rifampicin | multiple interactions | EXP | | 6480464 | [Rifampin co-treated with NR1I2 protein] results in increased expression of EGR1 mRNA | CTD | PMID:21127053 |
EGR1 | Human | risperidone | decreases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Risperidone results in decreased expression of EGR1 protein | CTD | PMID:17028028 |
EGR1 | Human | ropinirole | decreases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | ropinirole results in decreased expression of EGR1 mRNA | CTD | PMID:20452347 |
EGR1 | Human | rotenone | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Rotenone results in increased expression of EGR1 mRNA | CTD | PMID:19664596 |
EGR1 | Human | rotenone | decreases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Rotenone results in decreased expression of EGR1 mRNA | CTD | PMID:28374803 |
EGR1 | Human | rotenone | decreases expression | EXP | | 6480464 | Rotenone results in decreased expression of EGR1 mRNA | CTD | PMID:29955902 |
EGR1 | Human | S-adenosyl-L-methioninate | multiple interactions | EXP | | 6480464 | [S-Adenosylmethionine co-treated with Arsenic] affects the expression of EGR1 mRNA more ... | CTD | PMID:35490796 |
EGR1 | Human | S-adenosyl-L-methionine | multiple interactions | EXP | | 6480464 | [S-Adenosylmethionine co-treated with Arsenic] affects the expression of EGR1 mRNA more ... | CTD | PMID:35490796 |
EGR1 | Human | S-butyl-DL-homocysteine (S,R)-sulfoximine | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | Buthionine Sulfoximine promotes the reaction [Cadmium Chloride results in increased expression of EGR1 mRNA] | CTD | PMID:19010381 |
EGR1 | Human | sanguinarine | decreases expression | EXP | | 6480464 | sanguinarine results in decreased expression of EGR1 protein | CTD | PMID:23660334 |
EGR1 | Human | sanguinarine | increases expression | EXP | | 6480464 | sanguinarine results in increased expression of EGR1 protein | CTD | PMID:23660334 |
EGR1 | Human | sanguinarine | multiple interactions | EXP | | 6480464 | sanguinarine promotes the reaction [Reactive Oxygen Species results in increased activity of EGR1 protein] | CTD | PMID:23660334 |
EGR1 | Human | SB 203580 | multiple interactions | EXP | | 6480464 | SB 203580 inhibits the reaction [Fluorouracil results in increased expression of EGR1 mRNA] more ... | CTD | PMID:12482581 and PMID:18757417 |
EGR1 | Human | SB 203580 | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | SB 203580 inhibits the reaction [Quercetin results in increased expression of EGR1 mRNA] and SB 203580 inhibits the reaction [Quercetin results in increased expression of EGR1 protein] | CTD | PMID:22174042 |
EGR1 | Human | SB 203580 | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | SB 203580 inhibits the reaction [Anisomycin results in increased expression of EGR1 mRNA] more ... | CTD | PMID:22046279 more ... |
EGR1 | Human | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 |
EGR1 | Human | SCH 23390 | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | SCH 23390 inhibits the reaction [[Reserpine co-treated with Levodopa] results in increased expression of EGR1 mRNA] more ... | CTD | PMID:1347779 more ... |
EGR1 | Human | scopolamine | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | [Scopolamine co-treated with 2 more ... | CTD | PMID:8861055 |
EGR1 | Human | scopolamine | decreases expression | ISO | Egr1 (Mus musculus) | 6480464 | Scopolamine results in decreased expression of EGR1 protein | CTD | PMID:29133030 |
EGR1 | Human | scopolamine | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | Donepezil inhibits the reaction [Scopolamine results in decreased expression of EGR1 protein] and protopanaxadiol inhibits the reaction [Scopolamine results in decreased expression of EGR1 protein] | CTD | PMID:29133030 |
EGR1 | Human | scopolamine | decreases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Scopolamine results in decreased expression of EGR1 mRNA | CTD | PMID:17540011 and PMID:8861055 |
EGR1 | Human | selenium atom | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | [Selenium deficiency co-treated with Vitamin E deficiency] results in increased expression of EGR1 mRNA | CTD | PMID:11444866 |
EGR1 | Human | serpentine asbestos | increases expression | EXP | | 6480464 | Asbestos and Serpentine results in increased expression of EGR1 mRNA | CTD | PMID:32123850 |
EGR1 | Human | serpentine asbestos | multiple interactions | EXP | | 6480464 | clinoptilolite inhibits the reaction [Asbestos and Serpentine results in increased expression of EGR1 mRNA] | CTD | PMID:32123850 |
EGR1 | Human | sevoflurane | affects expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | sevoflurane affects the expression of EGR1 mRNA | CTD | PMID:15967596 |
EGR1 | Human | silibinin | increases expression | EXP | | 6480464 | Silybin results in increased expression of EGR1 protein | CTD | PMID:24440808 |
EGR1 | Human | silibinin | multiple interactions | EXP | | 6480464 | EGR1 mutant form inhibits the reaction [Silybin results in increased expression of GDF15 protein] | CTD | PMID:24440808 |
EGR1 | Human | silicon dioxide | decreases expression | EXP | | 6480464 | Silicon Dioxide analog results in decreased expression of EGR1 mRNA and Silicon Dioxide results in decreased expression of EGR1 mRNA | CTD | PMID:25895662 and PMID:27917503 |
EGR1 | Human | silicon dioxide | decreases expression | ISO | Egr1 (Mus musculus) | 6480464 | Silicon Dioxide results in decreased expression of EGR1 mRNA | CTD | PMID:29341224 |
EGR1 | Human | silicon dioxide | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | Silicon Dioxide results in increased expression of EGR1 mRNA | CTD | PMID:19073995 more ... |
EGR1 | Human | silicon dioxide | increases expression | EXP | | 6480464 | Silicon Dioxide analog results in increased expression of EGR1 mRNA and Silicon Dioxide results in increased expression of EGR1 mRNA | CTD | PMID:22300531 more ... |
EGR1 | Human | silicon dioxide | multiple interactions | EXP | | 6480464 | Silicon Dioxide results in increased expression of and affects the localization of and results in increased activity of EGR1 protein more ... | CTD | PMID:23874821 |
EGR1 | Human | silver atom | decreases expression | EXP | | 6480464 | Silver results in decreased expression of EGR1 mRNA | CTD | PMID:28959546 |
EGR1 | Human | silver atom | increases expression | EXP | | 6480464 | Silver analog results in increased expression of EGR1 mRNA and Silver results in increased expression of EGR1 mRNA | CTD | PMID:24462830 more ... |
EGR1 | Human | silver(0) | decreases expression | EXP | | 6480464 | Silver results in decreased expression of EGR1 mRNA | CTD | PMID:28959546 |
EGR1 | Human | silver(0) | increases expression | EXP | | 6480464 | Silver analog results in increased expression of EGR1 mRNA and Silver results in increased expression of EGR1 mRNA | CTD | PMID:24462830 more ... |
EGR1 | Human | simvastatin | decreases expression | ISO | Egr1 (Mus musculus) | 6480464 | Simvastatin results in decreased expression of EGR1 protein | CTD | PMID:12818400 |
EGR1 | Human | SKF 38393 | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | 2 more ... | CTD | PMID:20452347 |
EGR1 | Human | SKF 38393 | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | [Scopolamine co-treated with 2 more ... | CTD | PMID:8861055 |
EGR1 | Human | SL-327 | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | SL 327 inhibits the reaction [Chenodeoxycholic Acid results in increased expression of EGR1 mRNA] more ... | CTD | PMID:11553284 more ... |
EGR1 | Human | sodium arsenate | decreases expression | ISO | Egr1 (Mus musculus) | 6480464 | sodium arsenate results in decreased expression of EGR1 mRNA | CTD | PMID:21795629 |
EGR1 | Human | sodium arsenite | affects methylation | EXP | | 6480464 | sodium arsenite affects the methylation of EGR1 gene | CTD | PMID:28589171 |
EGR1 | Human | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of EGR1 mRNA | CTD | PMID:12016162 more ... |
EGR1 | Human | sodium arsenite | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | sodium arsenite results in increased expression of EGR1 and sodium arsenite results in increased expression of EGR1 mRNA | CTD | PMID:23523789 more ... |
EGR1 | Human | sodium arsenite | decreases expression | ISO | Egr1 (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of EGR1 mRNA | CTD | PMID:18812580 more ... |
EGR1 | Human | sodium arsenite | affects expression | ISO | Egr1 (Mus musculus) | 6480464 | sodium arsenite affects the expression of EGR1 mRNA | CTD | PMID:16507464 |
EGR1 | Human | sodium arsenite | increases response to substance | ISO | Egr1 (Mus musculus) | 6480464 | EGR1 results in increased susceptibility to sodium arsenite | CTD | PMID:21642427 |
EGR1 | Human | sodium arsenite | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | EGR1 gene mutant form inhibits the reaction [sodium arsenite results in increased expression of BAX protein] more ... | CTD | PMID:21642427 more ... |
EGR1 | Human | sodium arsenite | multiple interactions | EXP | | 6480464 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [sodium arsenite results in increased expression of EGR1 protein] more ... | CTD | PMID:15292961 more ... |
EGR1 | Human | sodium arsenite | increases stability | EXP | | 6480464 | sodium arsenite results in increased stability of EGR1 mRNA | CTD | PMID:25493608 |
EGR1 | Human | sodium arsenite | increases expression | EXP | | 6480464 | sodium arsenite results in increased expression of EGR1 mRNA and sodium arsenite results in increased expression of EGR1 protein | CTD | PMID:10910055 more ... |
EGR1 | Human | sodium atom | multiple interactions | EXP | | 6480464 | [EGR1 protein results in increased chemical synthesis of and results in increased activity of Reactive Oxygen Species] which results in decreased transport of Sodium | CTD | PMID:12517959 |
EGR1 | Human | sodium azide | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | Sodium Azide inhibits the reaction [Adenosine Triphosphate results in increased expression of EGR1 mRNA] | CTD | PMID:10723097 |
EGR1 | Human | sodium chloride | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Sodium Chloride results in increased expression of EGR1 | CTD | PMID:16280599 |
EGR1 | Human | sodium chloride | decreases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Sodium Chloride results in decreased expression of EGR1 mRNA | CTD | PMID:37992803 |
EGR1 | Human | sodium dichromate | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | sodium bichromate results in increased expression of EGR1 mRNA | CTD | PMID:27859739 |
EGR1 | Human | sodium dichromate | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | sodium bichromate results in increased expression of EGR1 mRNA | CTD | PMID:22561333 and PMID:25993096 |
EGR1 | Human | sodium dichromate | decreases expression | EXP | | 6480464 | sodium bichromate results in decreased expression of EGR1 mRNA | CTD | PMID:12760830 |
EGR1 | Human | sodium dodecyl sulfate | increases expression | EXP | | 6480464 | Sodium Dodecyl Sulfate results in increased expression of EGR1 mRNA | CTD | PMID:25377654 and PMID:31734321 |
EGR1 | Human | sodium tungstate | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | sodium tungstate(VI) results in increased expression of EGR1 mRNA | CTD | PMID:24619124 |
EGR1 | Human | Soman | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Soman results in increased expression of EGR1 mRNA | CTD | PMID:19281266 |
EGR1 | Human | styrene | increases expression | EXP | | 6480464 | Styrene results in increased expression of EGR1 mRNA | CTD | PMID:24086524 |
EGR1 | Human | styrene | affects expression | ISO | Egr1 (Mus musculus) | 6480464 | Styrene affects the expression of EGR1 mRNA | CTD | PMID:28951217 |
EGR1 | Human | succimer | multiple interactions | EXP | | 6480464 | [Succimer co-treated with Magnetite Nanoparticles] affects the expression of EGR1 mRNA | CTD | PMID:26378955 |
EGR1 | Human | sulfasalazine | decreases expression | ISO | Egr1 (Mus musculus) | 6480464 | Sulfasalazine results in decreased expression of EGR1 mRNA | CTD | PMID:31830553 |
EGR1 | Human | sulindac sulfide | multiple interactions | EXP | | 6480464 | EGR1 protein affects the reaction [sulindac sulfide results in increased expression of THBS1 mRNA] more ... | CTD | PMID:15509713 more ... |
EGR1 | Human | sulindac sulfide | increases expression | EXP | | 6480464 | sulindac sulfide results in increased expression of EGR1 mRNA and sulindac sulfide results in increased expression of EGR1 protein | CTD | PMID:15509713 more ... |
EGR1 | Human | sulprostone | increases expression | EXP | | 6480464 | sulprostone results in increased expression of EGR1 mRNA and sulprostone results in increased expression of EGR1 protein | CTD | PMID:20335389 |
EGR1 | Human | sunitinib | decreases expression | EXP | | 6480464 | Sunitinib results in decreased expression of EGR1 mRNA | CTD | PMID:31533062 |
EGR1 | Human | tacrolimus hydrate | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Tacrolimus results in increased expression of EGR1 mRNA | CTD | PMID:21865292 |
EGR1 | Human | tamoxifen | multiple interactions | EXP | | 6480464 | [Tamoxifen co-treated with ESR2 protein] results in increased expression of EGR1 mRNA | CTD | PMID:19059307 |
EGR1 | Human | tamoxifen | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | [bexarotene co-treated with Tamoxifen] results in decreased expression of EGR1 mRNA | CTD | PMID:17630414 |
EGR1 | Human | tamoxifen | affects expression | ISO | Egr1 (Mus musculus) | 6480464 | Tamoxifen affects the expression of EGR1 mRNA | CTD | PMID:20937368 |
EGR1 | Human | taurocholic acid | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | EGR1 promotes the reaction [Taurocholic Acid results in increased expression of CCL2 mRNA] more ... | CTD | PMID:21224055 |
EGR1 | Human | taurocholic acid | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | Taurocholic Acid results in increased expression of EGR1 mRNA and Taurocholic Acid results in increased expression of EGR1 protein | CTD | PMID:21224055 |
EGR1 | Human | tebufenpyrad | increases expression | EXP | | 6480464 | 4-chloro-N-((4-(1 and 1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in increased expression of EGR1 mRNA | CTD | PMID:33512557 |
EGR1 | Human | tert-butyl hydroperoxide | increases expression | EXP | | 6480464 | tert-Butylhydroperoxide results in increased expression of EGR1 mRNA | CTD | PMID:12414654 |
EGR1 | Human | tert-butyl hydroperoxide | affects expression | EXP | | 6480464 | tert-Butylhydroperoxide affects the expression of EGR1 mRNA | CTD | PMID:23410634 |
EGR1 | Human | Tesaglitazar | decreases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | tesaglitazar results in decreased expression of EGR1 mRNA | CTD | PMID:21515302 |
EGR1 | Human | testosterone | multiple interactions | EXP | | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of EGR1 mRNA | CTD | PMID:21592394 |
EGR1 | Human | testosterone | increases expression | EXP | | 6480464 | Testosterone results in increased expression of EGR1 mRNA | CTD | PMID:21592394 |
EGR1 | Human | tetrachloromethane | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | PLG gene mutant form promotes the reaction [Carbon Tetrachloride results in increased expression of EGR1 mRNA] | CTD | PMID:16006527 |
EGR1 | Human | tetrachloromethane | affects expression | ISO | Egr1 (Mus musculus) | 6480464 | Carbon Tetrachloride affects the expression of EGR1 mRNA | CTD | PMID:31919559 |
EGR1 | Human | tetrachloromethane | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of EGR1 mRNA | CTD | PMID:15056808 and PMID:27339419 |
EGR1 | Human | tetrodotoxin | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | Tetrodotoxin inhibits the reaction [ciguatoxin 3C results in increased expression of EGR1 mRNA] | CTD | PMID:25945544 |
EGR1 | Human | thapsigargin | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | Thapsigargin results in increased expression of EGR1 mRNA | CTD | PMID:8764118 |
EGR1 | Human | thapsigargin | decreases expression | EXP | | 6480464 | Thapsigargin results in decreased expression of EGR1 mRNA | CTD | PMID:22378314 |
EGR1 | Human | thapsigargin | increases expression | EXP | | 6480464 | Thapsigargin results in increased expression of EGR1 mRNA | CTD | PMID:21694771 |
EGR1 | Human | thifluzamide | increases expression | EXP | | 6480464 | thifluzamide results in increased expression of EGR1 mRNA | CTD | PMID:33512557 |
EGR1 | Human | thioacetamide | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Thioacetamide results in increased expression of EGR1 mRNA | CTD | PMID:23411599 and PMID:34492290 |
EGR1 | Human | thiram | increases expression | EXP | | 6480464 | Thiram results in increased expression of EGR1 mRNA | CTD | PMID:38568856 |
EGR1 | Human | titanium dioxide | decreases expression | ISO | Egr1 (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of EGR1 mRNA | CTD | PMID:29264374 |
EGR1 | Human | titanium dioxide | decreases methylation | ISO | Egr1 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of EGR1 promoter | CTD | PMID:35295148 |
EGR1 | Human | titanium dioxide | decreases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | titanium dioxide results in decreased expression of EGR1 mRNA | CTD | PMID:30012374 |
EGR1 | Human | titanium dioxide | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | titanium dioxide results in increased expression of EGR1 mRNA | CTD | PMID:23557971 |
EGR1 | Human | tocopherol | decreases activity | EXP | | 6480464 | Tocopherols results in decreased activity of EGR1 protein | CTD | PMID:15878867 |
EGR1 | Human | topotecan | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of EGR1 mRNA | CTD | PMID:25729387 |
EGR1 | Human | topotecan | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Topotecan results in increased expression of EGR1 mRNA | CTD | PMID:25729387 |
EGR1 | Human | trans-caffeic acid | multiple interactions | EXP | | 6480464 | caffeic acid affects the reaction [Acetaminophen results in increased expression of and affects the localization of EGR1 protein] and caffeic acid inhibits the reaction [Acetaminophen results in increased expression of EGR1 mRNA] | CTD | PMID:27720869 |
EGR1 | Human | tranylcypromine | decreases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Tranylcypromine results in decreased expression of EGR1 mRNA | CTD | PMID:7612155 |
EGR1 | Human | triacsin C | increases expression | EXP | | 6480464 | triacsin C results in increased expression of EGR1 mRNA | CTD | PMID:16704987 |
EGR1 | Human | triadimefon | increases expression | EXP | | 6480464 | triadimefon results in increased expression of EGR1 mRNA | CTD | PMID:26705709 |
EGR1 | Human | tributylstannane | decreases expression | ISO | Egr1 (Mus musculus) | 6480464 | tributyltin results in decreased expression of EGR1 mRNA | CTD | PMID:31939706 |
EGR1 | Human | Tributyltin oxide | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | bis(tri-n-butyltin)oxide results in increased expression of EGR1 mRNA | CTD | PMID:17553608 |
EGR1 | Human | trichloroethene | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | [Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in decreased expression of EGR1 mRNA | CTD | PMID:17905399 |
EGR1 | Human | trichloroethene | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | Trichloroethylene results in increased expression of EGR1 mRNA | CTD | PMID:29669109 |
EGR1 | Human | trichloroethene | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | [Trichloroethylene co-treated with Dietary Fats] results in increased expression of EGR1 mRNA | CTD | PMID:29669109 |
EGR1 | Human | trichloroethene | affects expression | ISO | Egr1 (Mus musculus) | 6480464 | Trichloroethylene affects the expression of EGR1 mRNA | CTD | PMID:25026505 |
EGR1 | Human | trichloroethene | decreases expression | ISO | Egr1 (Mus musculus) | 6480464 | Trichloroethylene results in decreased expression of EGR1 mRNA and Trichloroethylene results in decreased expression of EGR1 protein | CTD | PMID:25055964 |
EGR1 | Human | trichostatin A | multiple interactions | EXP | | 6480464 | [Doxorubicin co-treated with trichostatin A] results in increased expression of EGR1 mRNA more ... | CTD | PMID:17330857 and PMID:18801729 |
EGR1 | Human | trichostatin A | decreases expression | EXP | | 6480464 | trichostatin A results in decreased expression of EGR1 mRNA | CTD | PMID:24935251 |
EGR1 | Human | trichostatin A | affects expression | EXP | | 6480464 | trichostatin A affects the expression of EGR1 mRNA and trichostatin A affects the expression of EGR1 protein | CTD | PMID:18801729 |
EGR1 | Human | triphenyl phosphate | decreases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | triphenyl phosphate results in decreased expression of EGR1 mRNA | CTD | PMID:30589522 |
EGR1 | Human | triphenyl phosphate | affects expression | EXP | | 6480464 | triphenyl phosphate affects the expression of EGR1 mRNA | CTD | PMID:37042841 |
EGR1 | Human | Triton X-100 | increases expression | EXP | | 6480464 | Octoxynol results in increased expression of EGR1 mRNA | CTD | PMID:25377654 |
EGR1 | Human | troglitazone | multiple interactions | EXP | | 6480464 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [troglitazone results in increased expression of EGR1 mRNA] more ... | CTD | PMID:12475986 more ... |
EGR1 | Human | troglitazone | decreases expression | EXP | | 6480464 | troglitazone results in decreased expression of EGR1 mRNA | CTD | PMID:19631733 and PMID:25572481 |
EGR1 | Human | troglitazone | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | troglitazone inhibits the reaction [Oxygen deficiency results in increased expression of and results in increased activity of EGR1 protein] and troglitazone inhibits the reaction [Oxygen deficiency results in increased expression of EGR1 mRNA] | CTD | PMID:12468449 |
EGR1 | Human | troglitazone | decreases expression | ISO | Egr1 (Mus musculus) | 6480464 | troglitazone results in decreased expression of EGR1 mRNA and troglitazone results in decreased expression of EGR1 protein | CTD | PMID:12468449 and PMID:28973697 |
EGR1 | Human | troglitazone | increases activity | EXP | | 6480464 | troglitazone results in increased activity of EGR1 protein | CTD | PMID:12475986 |
EGR1 | Human | troglitazone | increases expression | EXP | | 6480464 | troglitazone results in increased expression of EGR1 mRNA and troglitazone results in increased expression of EGR1 protein | CTD | PMID:12475986 more ... |
EGR1 | Human | tropan-3alpha-yl 3-hydroxy-2-phenylpropanoate | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | Atropine inhibits the reaction [Pilocarpine results in increased expression of EGR1 mRNA] | CTD | PMID:7968354 |
EGR1 | Human | tungsten | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | [Tungsten co-treated with Nickel co-treated with Cobalt] results in increased expression of EGR1 mRNA and [Tungsten co-treated with Nickel co-treated with Iron] results in increased expression of EGR1 mRNA | CTD | PMID:24619124 |
EGR1 | Human | tungsten | decreases expression | ISO | Egr1 (Mus musculus) | 6480464 | Tungsten results in decreased expression of EGR1 mRNA | CTD | PMID:30912803 |
EGR1 | Human | tunicamycin | decreases expression | EXP | | 6480464 | Tunicamycin results in decreased expression of EGR1 mRNA | CTD | PMID:22378314 |
EGR1 | Human | tunicamycin | increases expression | EXP | | 6480464 | Tunicamycin results in increased expression of EGR1 mRNA | CTD | PMID:29453283 and PMID:33545341 |
EGR1 | Human | tyrphostin AG 1478 | multiple interactions | EXP | | 6480464 | RTKI cpd inhibits the reaction [sodium arsenite results in increased expression of EGR1 protein] | CTD | PMID:15292961 |
EGR1 | Human | urethane | increases expression | EXP | | 6480464 | Urethane results in increased expression of EGR1 mRNA | CTD | PMID:28818685 |
EGR1 | Human | ursodeoxycholic acid | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | Ursodeoxycholic Acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of EGR1 mRNA] | CTD | PMID:18590720 |
EGR1 | Human | valdecoxib | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | valdecoxib results in increased expression of EGR1 mRNA | CTD | PMID:24136188 |
EGR1 | Human | valproic acid | affects expression | ISO | Egr1 (Mus musculus) | 6480464 | Valproic Acid affects the expression of EGR1 mRNA | CTD | PMID:17963808 |
EGR1 | Human | valproic acid | decreases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | Valproic Acid results in decreased expression of EGR1 mRNA | CTD | PMID:29427782 |
EGR1 | Human | valproic acid | decreases expression | ISO | Egr1 (Mus musculus) | 6480464 | Valproic Acid results in decreased expression of EGR1 mRNA | CTD | PMID:29261810 |
EGR1 | Human | valproic acid | decreases methylation | EXP | | 6480464 | Valproic Acid results in decreased methylation of EGR1 gene | CTD | PMID:28853863 and PMID:29201983 |
EGR1 | Human | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of EGR1 mRNA | CTD | PMID:23179753 more ... |
EGR1 | Human | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of EGR1 mRNA | CTD | PMID:24935251 and PMID:28001369 |
EGR1 | Human | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of EGR1 mRNA | CTD | PMID:25979313 |
EGR1 | Human | valproic acid | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | Valproic Acid results in increased expression of EGR1 mRNA | CTD | PMID:20546886 |
EGR1 | Human | valsartan | multiple interactions | EXP | | 6480464 | Valsartan inhibits the reaction [AGT protein results in increased expression of EGR1 mRNA] and Valsartan inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased expression of EGR1 mRNA]] | CTD | PMID:19225232 |
EGR1 | Human | vancomycin | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | Vancomycin results in increased expression of EGR1 mRNA | CTD | PMID:18930951 |
EGR1 | Human | vecuronium bromide | multiple interactions | EXP | | 6480464 | Vecuronium Bromide inhibits the reaction [Nicotine results in increased expression of EGR1 mRNA] and Vecuronium Bromide inhibits the reaction [Nicotine results in increased expression of EGR1 protein] | CTD | PMID:29486207 |
EGR1 | Human | vinclozolin | decreases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | vinclozolin results in decreased expression of EGR1 mRNA | CTD | PMID:18220299 |
EGR1 | Human | vinclozolin | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | vinclozolin results in increased expression of EGR1 mRNA | CTD | PMID:23034163 and PMID:30207508 |
EGR1 | Human | vincristine | increases expression | EXP | | 6480464 | Vincristine results in increased expression of EGR1 mRNA | CTD | PMID:12706485 and PMID:23649840 |
EGR1 | Human | vitamin E | decreases expression | EXP | | 6480464 | Vitamin E results in decreased expression of EGR1 mRNA | CTD | PMID:19244175 |
EGR1 | Human | vitamin E | multiple interactions | ISO | Egr1 (Rattus norvegicus) | 6480464 | [Selenium deficiency co-treated with Vitamin E deficiency] results in increased expression of EGR1 mRNA | CTD | PMID:11444866 |
EGR1 | Human | vorinostat | increases expression | EXP | | 6480464 | vorinostat results in increased expression of EGR1 mRNA | CTD | PMID:27188386 |
EGR1 | Human | xanomeline | increases expression | ISO | Egr1 (Rattus norvegicus) | 6480464 | xanomeline results in increased expression of EGR1 mRNA | CTD | PMID:11313039 |
EGR1 | Human | zearalenone | increases expression | EXP | | 6480464 | Zearalenone results in increased expression of EGR1 mRNA | CTD | PMID:36828454 |
EGR1 | Human | zidovudine | multiple interactions | EXP | | 6480464 | [Zidovudine co-treated with Arsenic Trioxide] results in increased expression of EGR1 mRNA | CTD | PMID:29910624 |
EGR1 | Human | zinc atom | decreases expression | EXP | | 6480464 | Zinc deficiency results in decreased expression of EGR1 protein | CTD | PMID:12107072 |
EGR1 | Human | zinc atom | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | Zinc results in increased expression of EGR1 mRNA and Zinc results in increased expression of EGR1 protein | CTD | PMID:10428039 |
EGR1 | Human | zinc atom | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Zinc results in increased expression of EGR1 protein] more ... | CTD | PMID:10428039 and PMID:33549593 |
EGR1 | Human | zinc atom | increases expression | EXP | | 6480464 | Zinc results in increased expression of EGR1 protein | CTD | PMID:12107072 |
EGR1 | Human | zinc atom | multiple interactions | EXP | | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of EGR1 mRNA | CTD | PMID:18593933 |
EGR1 | Human | zinc molecular entity | decreases expression | EXP | | 6480464 | Zinc Compounds results in decreased expression of EGR1 mRNA | CTD | PMID:24035972 |
EGR1 | Human | zinc pyrithione | increases expression | EXP | | 6480464 | pyrithione zinc results in increased expression of EGR1 mRNA | CTD | PMID:19809895 |
EGR1 | Human | zinc(0) | decreases expression | EXP | | 6480464 | Zinc deficiency results in decreased expression of EGR1 protein | CTD | PMID:12107072 |
EGR1 | Human | zinc(0) | multiple interactions | EXP | | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of EGR1 mRNA | CTD | PMID:18593933 |
EGR1 | Human | zinc(0) | increases expression | EXP | | 6480464 | Zinc results in increased expression of EGR1 protein | CTD | PMID:12107072 |
EGR1 | Human | zinc(0) | multiple interactions | ISO | Egr1 (Mus musculus) | 6480464 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Zinc results in increased expression of EGR1 protein] more ... | CTD | PMID:10428039 and PMID:33549593 |
EGR1 | Human | zinc(0) | increases expression | ISO | Egr1 (Mus musculus) | 6480464 | Zinc results in increased expression of EGR1 mRNA and Zinc results in increased expression of EGR1 protein | CTD | PMID:10428039 |
EGR1 | Human | zoledronic acid | increases expression | EXP | | 6480464 | zoledronic acid results in increased expression of EGR1 mRNA | CTD | PMID:20977926 |
EGR1 | Human | zoledronic acid | decreases expression | EXP | | 6480464 | zoledronic acid results in decreased expression of EGR1 mRNA | CTD | PMID:24714768 |